Metal iridium complex and organic electroluminescent device
By using metal iridium complex with specific structures as red luminescent dopants, the luminescence efficiency and life of organic electroluminescent devices are improved, and the problems of phosphorescent materials stability and color saturation in the prior art are solved, achieving high efficiency , long-lived OLED performance.
Patent Information
- Application Number
- PCT/CN2024/087873
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-03-18
- Filing Date
- 2024-04-16
- Publication Date
- 2024-11-14
AI Technical Summary
The luminescence efficiency, driving voltage and service life of existing organic electroluminescent devices still need to be improved, especially the thermal stability, life and color saturation of phosphorescent materials.
Using a metal iridium complex of a specific structure, such as the general formula of Ir(La)(Lb)(Lc), where La is a ligand, Lb and Lc are monoanionic bidentate ligands, by adjusting the structure of the ligand to Form a highly rigid compound, improves photo, electrochemical stability and color saturation, and is used in OLEDs as a red luminescent dopant.
It achieves high efficiency and long life organic electroluminescent devices with narrow half-maximum width and high color saturation, and is suitable for the OLED industry, especially in display and lighting applications.
Smart Images

Figure CN2024087873_14112024_PF_FP_ABST
Abstract
Description
Metal iridium complex and organic electroluminescent device Technical Field
[0001] The present application relates to the technical field of organic electroluminescence, in particular to organic luminescent materials, and more particularly to a metal iridium complex and an organic electroluminescent device using the metal iridium complex. Background Art
[0002] Organic light-emitting diodes (OLEDs), a next-generation display technology, are gaining increasing attention in both display and lighting applications, boasting a broad range of applications. However, compared to market requirements, OLED device performance, including luminous efficiency, driving voltage, and lifespan, still requires further improvement.
[0003] Generally speaking, the basic structure of an OLED device is a thin film of organic functional materials with various functions sandwiched between a metal iridium electrode, like a sandwich structure. Driven by electric current, holes and electrons are injected from the anode and cathode respectively. After moving a certain distance, the holes and electrons are recombined in the light-emitting layer and released in the form of light or heat, thereby generating the luminescence of the OLED.
[0004] However, organic functional materials are the core components of organic electroluminescent devices. The thermal stability, photochemical stability, electrochemical stability, quantum yield, film formation stability, crystallinity, color saturation, etc. of the materials are all major factors affecting the performance of the device.
[0005] Generally, organic functional materials include fluorescent materials and phosphorescent materials. Fluorescent materials are usually organic small molecule materials, which can generally only utilize 25% of the singlet state to emit light, so the luminous efficiency is relatively low. However, due to the spin-orbit coupling caused by the heavy atom effect, phosphorescent materials can utilize the energy of 75% of the triplet excitons in addition to the 25% singlet state, so the luminous efficiency can be greatly improved. However, compared with fluorescent materials, phosphorescent materials started later, and the thermal stability, lifespan, color saturation, etc. of the materials need to be improved, which is a challenging topic. Various organometallic iridium compounds have been developed as such phosphorescent materials. For example, the invention patent document CN1589307A discloses a class of metal iridium complexes with quinoline, isoquinoline and benzene ring-connected compounds as ligands. In particular, iridium complexes can provide 500-700nm luminescence, and point out that the luminescence color of the compound can be adjusted by selecting electron-donating or electron-withdrawing groups at specific positions; invention patent document CN102627671B discloses an iridium compound with an atom bridge between isoquinoline and phenyl. It can improve oxidation stability and obtain high thermal stability, which helps to improve the life of the device. Invention patent document CN104885248B discloses an iridium complex with benzisoquinoline connected to phenyl as a ligand. The applicant pointed out that by adjusting the collocation and combination of the light-emitting layer, higher device efficiency and life can be provided; the invention patent document US20170012223A1 discloses an iridium complex of isoquinoline with an alkyl-substituted benzene ring connected by a dimethyl bridge However, the compound emits orange light, and the light color does not meet the application requirements. Invention patent document US20220306666A1 reports an iridium complex of benzisoquinoline through a bridged benzene ring. This type of compound has a narrow half-peak width and good luminous efficiency, but the light is orange-yellow, and the light color does not meet the application requirements. At the same time, the device life needs to be improved. Invention patents CN115260243A and CN114437134A disclose iridium complexes of quinoline / isoquinoline with naphthalene structures through oxygen-like bridges, and organic electroluminescent devices and compounds containing the complexes. This type of compound has a narrow half-width, but the device efficiency and lifespan still need to be further improved to meet the growing market demand. Therefore, the applicant still hopes to further develop new materials that improve the performance of organic electroluminescent devices.
[0006] Summary of the Invention
[0007] The present application has been made to solve the above-mentioned problems, and an object of the present application is to provide a high-performance organic electroluminescent device and a novel material capable of realizing such an organic electroluminescent device.
[0008] The present applicant has conducted intensive studies to achieve the aforementioned object and has found that a high-performance organic electroluminescent device can be obtained by using a metal iridium complex containing a structure represented by the following formula (1) as a ligand.
[0009] One of the objectives of this application is to provide a metal iridium complex that exhibits advantages such as high optical and electrochemical stability, narrow half-width (FWHM), high color saturation, high luminous efficiency, and long device life, and can be used in organic electroluminescent devices. In particular, it has potential applications in the OLED industry as a red-emitting dopant.
[0010] A metal iridium complex having the general formula of Ir(La)(Lb)(Lc) and a structural formula as shown in formula (1),
[0011] in is the ligand La;
[0012] wherein Z is independently selected from CRA R B ;
[0013] Wherein, X1-X9 are independently N or CR0, and adjacent substituents R0 can be optionally connected to form a ring;
[0014] wherein X1-X5 have at least two adjacent CR0s which can be connected to form an aromatic ring of 6-30 carbon atoms or a heteroaromatic ring of 3-30 carbon atoms;
[0015] Among them, R0, R, R A 、R B independently selected from hydrogen, deuterium, halogen, substituted or unsubstituted alkyl with 1-10 main chain carbon atoms, substituted or unsubstituted cycloalkyl with 3-20 ring carbon atoms, substituted or unsubstituted heteroalkyl with 1-10 main chain carbon atoms, substituted or unsubstituted heterocycloalkyl with 3-20 ring carbon atoms, substituted or unsubstituted C3-C30 alkylsilyl, substituted or unsubstituted C3-C30 alkylgermanyl, substituted or unsubstituted C1-C10 Alkoxy, substituted or unsubstituted C7-C30 aralkyl, substituted or unsubstituted C6-C30 aryloxy, substituted or unsubstituted C2-C20 alkenyl, substituted or unsubstituted C2-C20 alkynyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C3-C30 heteroaryl, substituted or unsubstituted C3-C30 arylsilyl, substituted or unsubstituted C0-C20 alkylamino, cyano, isocyano, phosphino;
[0016] Wherein, the R0, R, R A 、R B The substitution is substituted by deuterium, F, Cl, Br, C1-C4 alkyl, C1-C4 alkoxy, C3-C6 cycloalkyl, C1-C4 alkyl-substituted amino, C6-C10 aryl, C1-C4 alkyl-substituted C6-C10 aryl, cyano, isocyano, or phosphino;
[0017] wherein the heteroatom in the heteroalkyl, heterocycloalkyl, heteroaromatic ring or heteroaryl group is at least one of S, O, Se, B, P, N, Si and Ge;
[0018] Wherein, Lb and Lc are both monoanionic bidentate ligands, or La, Lb and Lc are arbitrarily connected to each other in pairs to form a multidentate ligand, or the three are connected through a group;
[0019] Wherein, the structural formula of Lb and / or Lc is as follows: shown.
[0020] As the metal iridium complex in some embodiments of the present application, the ligand La has one of the following structural formulas (2) to (19):
[0021] Wherein Y is selected from O, S, Se, CR A R B 、SiR A R B ,GeR A R B NR A R B BR A R B PR A R B ;
[0022] Y1-Y8 are independently N or CR0, or the substituents R0 adjacent to CR0 in Y1-Y8 can be optionally connected to form a ring;
[0023] Among them, X1-X9, R0, R, R A 、R B , Z are consistent with the above definitions.
[0024] As the metal iridium complex in some embodiments of the present application, wherein Lb is a structure shown in formula (21):
[0025] The dotted line indicates the position connected to the metal iridium Ir;
[0026] Among them, R a -R g independently selected from hydrogen, deuterium, halogen, substituted or unsubstituted alkyl with 1-10 main chain carbon atoms, substituted or unsubstituted cycloalkyl with 3-20 ring carbon atoms, substituted or unsubstituted heteroalkyl with 1-10 main chain carbon atoms, substituted or unsubstituted heterocycloalkyl with 3-20 ring carbon atoms, or R a 、R b 、R c They are connected in pairs to form a fatty ring structure, R e 、R f 、R g are connected in pairs to form a fatty ring structure; wherein the R a -R g The substitution is substituted by deuterium, F, Cl, Br, C1-C4 alkyl, C1-C4 alkoxy, C3-C6 cycloalkyl, C1-C4 alkyl substituted by amino, cyano, isocyano, phosphino.
[0027] R a 、R b 、Rc 、R e 、R f、 R g independently selected from hydrogen, deuterium, halogen, substituted or unsubstituted alkyl with 1 to 10 main chain carbon atoms, substituted or unsubstituted cycloalkyl with 3 to 20 ring carbon atoms, or R a 、R b 、R c They are connected in pairs to form a fatty ring structure, R e 、R f 、R g They are connected in pairs to form a fatty ring structure; R d is selected from hydrogen, deuterium, halogen, substituted or unsubstituted alkyl with 1 to 10 main chain carbon atoms, wherein R a -R g The substitution is by deuterium, F, Cl, Br, C1-C4 alkyl, or C3-C6 cycloalkyl.
[0028] R a 、R b 、R c Respectively with R e 、R f 、R g same.
[0029] As the metal iridium complex in some embodiments of the present application, wherein R is an alkyl group having 1-10 carbon atoms, a substituted or unsubstituted cycloalkyl group having 3-20 ring carbon atoms, a substituted or unsubstituted C3-C30 alkylsilyl group, or a substituted or unsubstituted C3-C30 alkylgermanyl group.
[0030] As the metal iridium complex in some embodiments of the present application, the ligand La has the following structural formula (22):
[0031] Wherein, X1-X5, R0, R, and Z are consistent with the above definitions; R1-R4 are independently selected from hydrogen, deuterium, halogen, substituted or unsubstituted alkyl with 1-10 main chain carbon atoms, substituted or unsubstituted cycloalkyl with 3-20 ring carbon atoms, substituted or unsubstituted heteroalkyl with 1-10 main chain carbon atoms, substituted or unsubstituted heterocycloalkyl with 3-20 ring carbon atoms, substituted or unsubstituted C3-C30 alkylsilyl, substituted or unsubstituted C1-C10 alkoxy, substituted or unsubstituted C7-C30 aralkyl, substituted or unsubstituted C6-C30 aryloxy, a substituted or unsubstituted C6-C30 aryl group, a substituted or unsubstituted C3-C30 heteroaryl group, a substituted or unsubstituted C3-C30 arylsilyl group, a substituted or unsubstituted C0-C20 alkylamino group, a cyano group, an isocyano group, or a phosphino group, and adjacent substituents R1-R4 can be optionally linked to form a ring, and the substitutions in R1-R4 are substituted by deuterium, F, Cl, Br, C1-C4 alkyl, C1-C4 alkoxy, C3-C6 cycloalkyl, an amino group substituted by a C1-C4 alkyl group, a C6-C10 aryl group, a C6-C10 aryl group substituted by a C1-C4 alkyl group, a cyano group, or an isocyano group.
[0032] As the metal iridium complex in some embodiments of the present application, the ligand La has one of the following structural formulas (23)-(24):
[0033] Wherein, X1-X3 are independently N or CR0, and two adjacent CR0s in X1-X3 can be connected to form an aromatic ring with 6-30 carbon atoms or a heteroaromatic ring with 3-30 carbon atoms.
[0034] wherein R0, R, and Z are as defined above; R1-R6 are independently selected from hydrogen, deuterium, halogen, substituted or unsubstituted alkyl with 1-8 main chain carbon atoms, substituted or unsubstituted cycloalkyl with 3-10 ring carbon atoms, substituted or unsubstituted heteroalkyl with 1-8 main chain carbon atoms, substituted or unsubstituted heterocycloalkyl with 3-10 ring carbon atoms, substituted or unsubstituted C3-C20 alkylsilyl, substituted or unsubstituted C1-C8 alkoxy, substituted or unsubstituted C7-C20 aralkyl, substituted or unsubstituted C6-C20 aryloxy, substituted or unsubstituted C The present invention also comprises a C6-C20 aryl group, a substituted or unsubstituted C3-C20 heteroaryl group, a substituted or unsubstituted C3-C20 arylsilyl group, a substituted or unsubstituted C0-C10 alkylamino group, a cyano group, an isocyano group, a phosphino group, or adjacent substituents R1-R4, R5-R6 can be optionally connected to form a ring, and the substitution in R1-R6 is substituted by deuterium, F, Cl, Br, C1-C4 alkyl, C1-C4 alkoxy, C3-C6 cycloalkyl, an amino group substituted by C1-C4 alkyl, a C6-C10 aryl group, a C6-C10 aryl group substituted by a C1-C4 alkyl, a cyano group, or an isocyano group.
[0035] In some embodiments of the present invention, in the metal iridium complex, wherein in the ligand La, X1-X3 are independently N or CR0; Z is independently selected from CR A R B ; R, R A 、R B , R1-R6 are independently selected from hydrogen, deuterium, halogen, substituted or unsubstituted alkyl having 1-10 main chain carbon atoms, substituted or unsubstituted cycloalkyl having 3-20 ring carbon atoms, substituted or unsubstituted heteroalkyl having 1-10 main chain carbon atoms, substituted or unsubstituted heterocycloalkyl having 3-20 ring carbon atoms, substituted or unsubstituted C3-C30 alkylsilyl, substituted or unsubstituted C7-C30 aralkyl, substituted or unsubstituted C6-C30 aryloxy; two adjacent CROs are linked to form an aromatic ring of 6-30 carbon atoms or a heteroaromatic ring of 3-30 carbon atoms, or R5-R6 are linked to form an aromatic ring of 6-30 carbon atoms or a heteroaromatic ring of 3-30 carbon atoms.
[0036] In the metal iridium complex of some embodiments of the present application, Lc and La have the same structure, forming a (La)2Ir(Lb) structure.
[0037] As the metal iridium complex in some embodiments of the present application, wherein La is independently selected from one of the following structural formulas, or the hydrogen atoms in one of the following structural formulas are partially or completely deuterated, or the hydrogen atoms in one of the following structural formulas are partially or completely fluorinated:
[0038] As a metal iridium complex in some embodiments of the present application, wherein Lb is independently selected from one of the following structural formulas, or the hydrogen atoms in one of the following structural formulas are partially or completely deuterated, or the hydrogen atoms in one of the following structural formulas are partially or completely fluorinated:
[0039] Another object of the present invention is to provide an electroluminescent device comprising: a cathode, an anode, and an organic layer disposed between the cathode and the anode, wherein the organic layer comprises the metal iridium complex.
[0040] The organic layer comprises a light-emitting layer, and the metal iridium complex is used as a doping material for the light-emitting layer, preferably a red light-emitting doping material.
[0041] The materials of this application have advantages such as high optical and electrochemical stability, narrow half-width, high color saturation, high luminous efficiency, and long device life. As phosphorescent materials, the materials of this application can convert triplet excited states into light, thereby improving the luminous efficiency of organic electroluminescent devices and reducing energy consumption. BRIEF DESCRIPTION OF THE DRAWINGS
[0042] Figure 1 shows the structure of compound La016. 1 HNMR spectrum
[0043] Figure 2 shows the compound Ir(La016)2(Lb007) 1 HNMR spectrum
[0044] Figure 3 is the UV-PL spectrum of compound Ir(La016)2(Lb007) DETAILED DESCRIPTION
[0045] A metal iridium complex having the general formula of Ir(La)(Lb)(Lc) and a structural formula as shown in formula (1),
[0046] in is the ligand La;
[0047] wherein Z is independently selected from CR A R B ;
[0048] Wherein, X1-X9 are independently N or CR0, and adjacent substituents R0 can be optionally connected to form a ring;
[0049] wherein X1-X5 have at least two adjacent CR0s which can be connected to form an aromatic ring of 6-30 carbon atoms or a heteroaromatic ring of 3-30 carbon atoms;
[0050] Among them, R0, R, R A 、R B independently selected from hydrogen, deuterium, halogen, substituted or unsubstituted alkyl with 1-10 main chain carbon atoms, substituted or unsubstituted cycloalkyl with 3-20 ring carbon atoms, substituted or unsubstituted heteroalkyl with 1-10 main chain carbon atoms, substituted or unsubstituted heterocycloalkyl with 3-20 ring carbon atoms, substituted or unsubstituted C3-C30 alkylsilyl, substituted or unsubstituted C3-C30 alkylgermanyl, substituted or unsubstituted C1-C10 alkoxy, substituted or unsubstituted C7-C30 aralkyl, substituted or unsubstituted C6-C30 aryloxy, substituted or unsubstituted C2-C20 alkenyl, substituted or unsubstituted C2-C20 alkynyl, substituted or unsubstituted C6-C30 aryl and condensed ring aryl, substituted or unsubstituted C3-C30 heteroaryl and condensed ring heteroaryl, substituted or unsubstituted C3-C30 arylsilyl, substituted or unsubstituted C0-C20 alkylamino, cyano, isocyano, phosphino;
[0051] Wherein, the R0, R, R A 、R B The substitution is substituted by deuterium, F, Cl, Br, C1-C4 alkyl, C1-C4 alkoxy, C3-C6 cycloalkyl, C1-C4 alkyl-substituted amino, C6-C10 aryl, C1-C4 alkyl-substituted C6-C10 aryl, cyano, isocyano, or phosphino;
[0052] wherein the heteroatom in the heteroalkyl, heterocycloalkyl or heteroaryl group is at least one of S, O, Se, P, B, N, Si and Ge;
[0053] Wherein, Lb and Lc are both monoanionic bidentate ligands, or La, Lb and Lc are arbitrarily connected to each other in pairs to form a multidentate ligand, or the three are connected through a group;
[0054] Wherein, the structural formula of Lb and / or Lc is as follows: shown.
[0055] In some embodiments of the present application, the metal iridium complex, wherein the ligand La has one of the following structural formulas (2) to (19):
[0056] Wherein Y is selected from O, S, Se, CR A RB 、SiR A R B ,GeR A R B NR A R B BR A R B PR A R B ;
[0057] Y1-Y8 are independently N or CR0, and adjacent substituents R0 can be optionally connected to form a ring;
[0058] Among them, X1-X9, R0, R, R A 、R B , Z is consistent with the above definition;
[0059] In some embodiments of the present application, the metal iridium complex, wherein Lb is a structure shown in formula (21):
[0060] The dotted line indicates the position connected to the metal iridium Ir;
[0061] Among them, R a -R g independently selected from hydrogen, deuterium, halogen, substituted or unsubstituted alkyl with 1-10 main chain carbon atoms, substituted or unsubstituted cycloalkyl with 3-20 ring carbon atoms, substituted or unsubstituted heteroalkyl with 1-10 main chain carbon atoms, substituted or unsubstituted heterocycloalkyl with 3-20 ring carbon atoms, or R a 、R b 、R c They are connected in pairs to form a fatty ring structure, R e 、R f 、R g are connected in pairs to form a fatty ring structure; wherein the R a -R g The substitution is substituted by deuterium, F, Cl, Br, C1-C4 alkyl, C1-C4 alkoxy, C3-C6 cycloalkyl, C1-C4 alkyl substituted by amino, cyano, isocyano, phosphino.
[0062] In some embodiments of the present application, the metal iridium complex, wherein Lc and La have the same structure, forms a (La)2Ir(Lb) structure.
[0063] R a 、R b 、R c Respectively with R e 、R f 、Rg same.
[0064] R a 、R b 、R c 、R e 、R f 、R g independently selected from hydrogen, deuterium, halogen, substituted or unsubstituted alkyl with 1 to 10 main chain carbon atoms, substituted or unsubstituted cycloalkyl with 3 to 20 ring carbon atoms, or R a 、R b 、R c They are connected in pairs to form a fatty ring structure, R e 、R f 、R g They are connected in pairs to form a fatty ring structure; R d is selected from hydrogen, deuterium, halogen, substituted or unsubstituted alkyl with 1 to 10 main chain carbon atoms, wherein R a -R g The substitution is by deuterium, F, Cl, Br, C1-C4 alkyl, or C3-C6 cycloalkyl.
[0065] In some embodiments of the present application, the metal iridium complex, wherein R is hydrogen, a substituted or unsubstituted alkyl group having 1-10 carbon atoms, a substituted or unsubstituted cycloalkyl group having 3-20 ring carbon atoms, a substituted or unsubstituted C3-C30 alkylsilyl group, or a substituted or unsubstituted C3-C30 alkylgermanyl group.
[0066] In some embodiments of the present application, the metal iridium complex, wherein the ligand La has the following structural formula (22):
[0067] Wherein, X1-X5, R0, R, and Z are consistent with the above definitions; R1-R4 are independently selected from hydrogen, deuterium, halogen, substituted or unsubstituted alkyl with 1-10 main chain carbon atoms, substituted or unsubstituted cycloalkyl with 3-20 ring carbon atoms, substituted or unsubstituted heteroalkyl with 1-10 main chain carbon atoms, substituted or unsubstituted heterocycloalkyl with 3-20 ring carbon atoms, substituted or unsubstituted C3-C30 alkylsilyl, substituted or unsubstituted C1-C10 alkoxy, substituted or unsubstituted C7-C30 aralkyl, substituted or unsubstituted C6-C30 aryloxy, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C3-C30 heteroaryl, substituted or unsubstituted C3-C30 arylsilyl, substituted or unsubstituted C0-C20 alkylamino, cyano, isocyano, phosphino, and adjacent substituents R1-R4 can be optionally linked to form a ring.
[0068] In some embodiments of the present application, the metal iridium complex, wherein the ligand La has one of the following structural formulas (23)-(24):
[0069] Wherein, X1-X3 are independently N or CR0, and two adjacent CR0s in X1-X3 can be connected to form an aromatic ring with 6-30 carbon atoms or a heteroaromatic ring with 3-30 carbon atoms.
[0070] Wherein, R0, R, and Z are consistent with the above definitions; R1-R6 are independently selected from hydrogen, deuterium, halogen, substituted or unsubstituted alkyl with 1-8 main chain carbon atoms, substituted or unsubstituted cycloalkyl with 3-10 ring carbon atoms, substituted or unsubstituted heteroalkyl with 1-8 main chain carbon atoms, substituted or unsubstituted heterocycloalkyl with 3-10 ring carbon atoms, substituted or unsubstituted C3-C20 alkylsilyl, substituted or unsubstituted C1-C8 alkoxy, substituted or unsubstituted C7-C20 aralkyl, substituted or unsubstituted C6-C20 aryloxy, substituted or unsubstituted C6-C20 aryl, substituted or unsubstituted C3-C20 heteroaryl, substituted or unsubstituted C3-C20 arylsilyl, substituted or unsubstituted C0-C10 alkylamino, cyano, isocyano, and adjacent substituents R1-R4, R5-R6 can be optionally linked to form a ring.
[0071] Hereinafter, examples of each group of the compound represented by formula (1) will be described.
[0072] In the present specification, the "carbon number a to b" in the expression "substituted or unsubstituted X group having a to b carbon atoms" refers to the carbon number of the unsubstituted X group and does not include the carbon number of the substituent when the X group is substituted.
[0073] The C1 to C10 alkyl group is a straight-chain or branched alkyl group, specifically, methyl, ethyl, propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl and its isomers, n-hexyl and its isomers, n-heptyl and its isomers, n-octyl and its isomers, n-nonyl and its isomers, n-decyl and its isomers, etc. In some embodiments of the present application, the alkyl group is methyl, ethyl, propyl, isopropyl, n-butyl, isobutyl, sec-butyl, and tert-butyl. In some embodiments of the present application, the alkyl group is propyl, isopropyl, isobutyl, sec-butyl, and tert-butyl.
[0074] Examples of the C3-C20 cycloalkyl group include cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, 1-adamantyl, 2-adamantyl, 1-norbornyl, 2-norbornyl, and the like. In some embodiments of the present application, the cycloalkyl group is cyclopentyl or cyclohexyl.
[0075] Examples of the C2 to C10 alkenyl group include vinyl, propenyl, allyl, 1-butadienyl, 2-butadienyl, 1-hexatrienyl, 2-hexatrienyl, and 3-hexatrienyl. In some embodiments of the present application, the alkenyl group is propenyl or allyl.
[0076] The C1-C10 heteroalkyl group is a straight-chain or branched alkyl group, cycloalkyl group, etc. composed of atoms other than carbon and hydrogen, and examples thereof include mercaptomethylmethane, methoxymethane, ethoxymethane, tert-butoxymethane, N,N-dimethylmethane, butylene oxide, cyclopentyl, hexyl oxide, etc. In some embodiments of the present application, the heteroalkyl group is methoxymethane or cyclopentyl.
[0077] Aryl groups include monocyclic aromatic groups, condensed aromatic groups, or non-condensed aromatic groups. Specific examples of aromatic groups include phenyl, naphthyl, anthracenyl, phenanthrenyl, naphthyl, pyrenyl, chrysene, benzo[c]phenanthrenyl, benzo[g]chrysene, fluorenyl, benzofluorenyl, dibenzofluorenyl, biphenyl, terphenyl, quaterphenyl, fluoranthenyl, etc. In some embodiments of the present application, they include phenyl and naphthyl.
[0078] The heteroaryl group includes a monocyclic heteroaryl group, a condensed ring heteroaryl group or a non-condensed ring heteroaryl group. Specific examples of the heteroaryl group include pyrrolyl, pyrazinyl, pyridyl, pyrimidinyl, triazinyl, indolyl, isoindolyl, imidazolyl, furyl, benzofuranyl, isobenzofuranyl, dibenzofuranyl, dibenzothiophenyl, azadibenzofuranyl, azadibenzothiophenyl, diazadibenzofuranyl, diazadibenzothiophenyl, quinolyl, isoquinolyl, quinoxalinyl, carbazolyl, phenanthridinyl, acridine The oxazine radicals include oxadiazolyl, phenanthroline radical, phenazinyl, phenothiazinyl, phenoxazinyl, oxazolinyl, oxadiazolyl, furazanyl, thienyl, benzothienyl, dihydroacridinyl, azacarbazolyl, diazacarbazolyl, quinazolinyl, and the like. In some embodiments of the present application, the oxazine radicals include pyridyl, pyrimidinyl, triazinyl, dibenzofuranyl, dibenzothienyl, azadibenzofuranyl, azadibenzothienyl, diazadibenzofuranyl, diazadibenzothienyl, carbazolyl, azacarbazolyl, and diazacarbazolyl.
[0079] The adjacent substituents R0 can be optionally linked to form a ring, which can be an aromatic ring, a heteroaromatic ring, or an aliphatic ring. For example, the two R0 on adjacent X1 and X2 are bonded to each other and to the C atoms on the aryl or heteroaryl groups of X1 and X2 to form an aromatic ring, a heteroaromatic ring, or an aliphatic ring. Similarly, X2 and X3, X3 and X4, X4 and X5, X6 and X7, X7 and X8, and X8 and X9 can be bonded to form an aromatic ring, a heteroaromatic ring, or an aliphatic ring. Similarly, adjacent substituents R1-R4 and R5-R6 can be optionally linked to form an aromatic ring, a heteroaromatic ring, or an aliphatic ring.
[0080] The following examples are only for facilitating understanding of the technical invention and should not be regarded as specific limitations of this application.
[0081] The raw materials and solvents involved in the synthesis of the compounds in this application were purchased from suppliers well known to those skilled in the art, such as Alfa and Acros.
[0082] Synthesis of ligand La008
[0083] Synthesis of compound La008-3
[0084] Compound La008-1 (50.00 g, 333.47 mmol), La008-2 (84.52 g, 333.47 mmol), tetrakis(triphenylphosphine)palladium (3.85 g, 3.33 mmol), potassium carbonate (92.17 g, 666.93 mmol), tetrahydrofuran (750 ml), and deionized water (250 ml) were added to a 2000 ml three-necked round-bottom flask. The flask was purged with nitrogen three times under vacuum. Under nitrogen protection, the flask was stirred at 65°C for 3 hours. TLC monitoring (developing solvent: ethyl acetate: petroleum ether = 1:20) indicated that the reaction of the starting material La008-2 was complete.
[0085] The mixture was cooled to room temperature and concentrated under reduced pressure to remove the organic solvent. Ethyl acetate (800 ml) was added and washed with deionized water (3*300 ml). The mixture was allowed to stand for separation. The organic phase was concentrated under reduced pressure at 65°C and then subjected to silica gel column chromatography (200-300 mesh silica gel, eluent: ethyl acetate: petroleum ether = 1:30). After elution, the mixture was concentrated under reduced pressure at 65°C for 1 hour to obtain a white solid compound La008-3 (63.70 g, purity: 99.67%, yield: 82.45%), mass spectrum: 232.05 (M+H).
[0086] Synthesis of compound La008-4
[0087] Compound La008-3 (62.00 g, 267.61 mmol), potassium tert-butoxide (60.06 g, 535.22 mmol), and N,N-dimethylformamide (900 ml) were added to a 2000 ml three-necked round-bottom flask. The atmosphere was replaced with nitrogen three times under vacuum. Under nitrogen protection, the mixture was stirred at 120°C for 6 hours. TLC monitoring (developing solvent: ethyl acetate: petroleum ether = 1:10) indicated that the reaction of the starting material La008-3 was complete.
[0088] Direct concentration was performed to remove N,N-dimethylformamide, ethyl acetate (600 ml) was added, and deionized water (3*300 ml) was added for washing. The liquids were separated, and the organic phase was concentrated and subjected to silica gel column chromatography (200-300 mesh silica gel, eluent: ethyl acetate: petroleum ether = 1:25). After concentration, a white solid was obtained, which was compound La008-4 (37.74 g, purity: 99.86%, yield: 66.00%), mass spectrum: 214.04 (M+H).
[0089] Synthesis of compound La008-7
[0090] Compound La008-5 (40.00 g, 179.32 mmol), La008-6 (36.16 g, 215.18 mmol), tetrakis(triphenylphosphine)palladium (2.07 g, 1.79 mmol), potassium carbonate (49.56 g, 358.63 mmol), tetrahydrofuran (600 ml), and deionized water (200 ml) were added to a 2000 ml three-necked round-bottom flask. The atmosphere was replaced with nitrogen three times under vacuum. Under nitrogen protection, the mixture was stirred at 70°C for 1 hour. TLC monitoring (developing solvent: ethyl acetate: petroleum ether = 1:20) indicated that the reaction of the starting material La008-5 was complete.
[0091] The mixture was cooled to room temperature and concentrated under reduced pressure to remove the organic solvent. Ethyl acetate (500 ml) was added and washed with deionized water (3*150 ml). The mixture was allowed to stand for separation. The organic phase was concentrated under reduced pressure at 65°C and then subjected to silica gel column chromatography (200-300 mesh silica gel, eluent: ethyl acetate: petroleum ether = 1:30). After elution, the mixture was concentrated under reduced pressure at 65°C for 1 hour to obtain a light brown oily liquid, compound La008-7 (28.29 g, purity: 99.53%, yield: 85.62%), mass spectrum: 185.28 (M+H).
[0092] Synthesis of compound La008-8
[0093] Compound La008-7 (27.00 g, 146.55 mmol), dichloromethane (350 ml), and triethylamine (29.65 g, 293.10 mmol) were added to a 1000 ml three-necked round-bottom flask and the atmosphere was purged with nitrogen three times. Under nitrogen protection, the system was cooled to 0°C and trifluoromethanesulfonic anhydride (53.74 g, 190.51 mmol) was added dropwise using a constant pressure dropping funnel over 30 minutes. The temperature was maintained with stirring for 30 minutes. TLC monitoring (developing solvent: ethyl acetate: petroleum ether = 1:20) indicated complete reaction of the starting material La008-7.
[0094] 100 ml of deionized water was added to the system, and the mixture was allowed to stand for separation. The organic phase was concentrated under reduced pressure at 65° C. and then subjected to silica gel column chromatography (200-300 mesh silica gel, eluent: petroleum ether). After elution, the mixture was concentrated under reduced pressure at 65° C. for 1 hour to obtain a light yellow oily liquid, compound La008-8 (41.72 g, purity: 99.32%, yield: 90.00%), mass spectrum: 317.02 (M+H)
[0095] Synthesis of compound La008-10
[0096] Compound La008-8 (38.00 g, 120.14 mmol), La008-9 (36.61 g, 144.17 mmol), 1,1-bis(diphenylphosphino)diphenylferric palladium chloride (1.74 g, 2.40 mmol), potassium acetate (23.58 g, 240.28 mmol), and 1,4-dioxane (400 ml) were added to a 1000 ml three-necked round-bottom flask. The atmosphere was purged with nitrogen three times under vacuum. Under nitrogen protection, the system was heated to 80°C and reacted for 4 hours. TLC monitoring (developing solvent: ethyl acetate: petroleum ether = 1:20) indicated complete reaction of the starting material La008-8.
[0097] The 1,4-dioxane was removed by concentration, ethyl acetate (500 ml) was added, and the mixture was washed with deionized water (3*200 ml). The mixture was allowed to stand for separation. The organic phase was concentrated under reduced pressure at 65°C and then subjected to silica gel column chromatography (200-300 mesh silica gel, eluent: ethyl acetate: petroleum ether = 1:30). After elution, the mixture was concentrated under reduced pressure at 65°C for 1 hour to obtain a white solid compound La008-10 (26.74 g, purity: 98.55%, yield: 75.64%), mass spectrum: 295.22 (M+H)
[0098] Synthesis of compound La008-11
[0099] Compound La008-4 (18.00 g, 84.24 mmol), La008-10 (26.02 g, 88.46 mmol), bis(4-dimethylaminophenyldi-tert-butylphosphine)palladium dichloride (1.19 g, 1.68 mmol), potassium carbonate (23.28 g, 168.48 mol), toluene (270 ml), ethanol (90 ml), and deionized water (90 ml) were added to a 1000 ml three-necked flask. The flask was purged with nitrogen three times under vacuum. Under nitrogen protection, the mixture was heated to 65°C and stirred for 5 hours. TLC monitoring (developing solvent: ethyl acetate: petroleum ether = 1:15) indicated that the reaction of the starting material La008-4 was complete.
[0100] The mixture was cooled to room temperature and concentrated under reduced pressure to remove the organic solvent. Ethyl acetate (600 ml) was added and washed with deionized water (3*200 ml). The liquids were separated and the organic phase was concentrated and then subjected to silica gel column chromatography (200-300 mesh silica gel, eluent: ethyl acetate: petroleum ether = 1:25). After concentration, a white solid was obtained, which was compound La008-11 (24.24 g, purity: 99.45%, yield: 83.31%), with a mass spectrum of 346.16 (M+H).
[0101] Synthesis of compound La008
[0102] Compound La008-11 (20.00 g, 57.90 mmol) and methanesulfonic acid (200 ml) were added to a 500 ml three-necked flask and the atmosphere was replaced with nitrogen three times. Under nitrogen protection, the mixture was heated to 100°C and stirred for 6 hours. TLC monitoring (developing solvent: ethyl acetate: petroleum ether = 1:15) indicated that the reaction of the starting material La008-11 was complete.
[0103] The mixture was cooled to 5°C, 200 ml of deionized water was added to quench the reaction, the precipitated solid was filtered, and the filter cake was washed with deionized water (200 ml) to obtain a white solid. 15 volumes of toluene and 5 volumes of methanol were used for crystallization. The precipitated solid was filtered, and the filter cake was vacuum dried at 90°C for 5 hours to obtain a white solid as compound La008 (11.03 g, purity: 99.86%, yield: 55.14%), mass spectrum: 346.16 (M+H).
[0104] Synthesis of Compound Ir(La008)2(Lb005)
[0105] Synthesis of Compound Ir(La008)-1
[0106] Compound La008 (10.00 g, 29.00 mmol) and iridium trichloride trihydrate (3.40 g, 9.66 mmol) were added to a 500 ml three-necked round-bottom flask. Ethylene glycol ether (130 ml) and deionized water (42 ml) were added. The mixture was replaced with nitrogen in vacuum three times, and then heated to 110 °C with stirring and reflux for 24 hours.
[0107] After cooling to room temperature, methanol (150 ml) was added, and the mixture was stirred at room temperature for 1 hour. The mixture was filtered, and the filter cake was washed with methanol (50 ml). The solid was dried under vacuum at 80°C to obtain compound Ir(La008)-1 (6.86 g, yield: 77.51%). The obtained compound was used directly in the next step without purification.
[0108] Synthesis of Compound Ir(La008)2(Lb005)
[0109] Compound Ir(La008)-1 (6.60 g, 3.60 mmol), Lb005 (3.82 g, 18.00 mmol), sodium carbonate (3.81 g, 36.00 mmol) and ethylene glycol ethyl ether (66 ml) were added to a 250 ml single-necked round-bottom flask. The mixture was replaced with vacuum nitrogen three times and stirred at 60 ° C for 24 hours. The reaction of Ir(La008)-1 was completed under TLC monitoring (developing solvent: methanol: dichloromethane = 1:100).
[0110] After cooling to room temperature, methanol (100 ml) was added and the mixture was slurried at room temperature for 1.5 hours. The mixture was then filtered with suction. The filter cake was dissolved in 300-400 mesh silica gel (50 g) using dichloromethane (100 ml). The filtrate was washed with deionized water (3*50 ml) and concentrated under reduced pressure at 60°C to obtain a red solid. The solid was recrystallized twice from toluene and methanol to obtain the red solid compound Ir(La008)2(Lb005) (3.44 g, purity: 99.83%, yield: 43.77%). 3.44 g of crude Ir(La008)2(Lb005) was purified by sublimation to obtain pure Ir(La008)2(Lb005) (2.48 g, purity: 99.80%, yield: 72.10%), mass spectrum: 1093.44 (M+H).
[0111] 1 H NMR (400MHz, CDCl3) δ8.40 (dd, J=6.0, 3.4Hz, 2H), 8.29 (d, J=2.2Hz, 2H), 8.24 -8.19(m,2H),8.18-8.14(m,3H),8.13(s,1H),7.95(m,2H),7.89-7.83(m,2H) ,7.55-7.49(m,4H),7.46(m,2H),7.33(m,2H),7.27(d,J=9.5Hz,2H),4.79(s, 1H),2.71(m,2H),1.67-1.54(m,16H),1.42-1.28(m,4H),0.95-0.83(m,12H).
[0112] Synthesis of ligand La013
[0113] Synthesis of compound La013-2
[0114] Referring to the synthesis and purification method of compound La008-3, only the corresponding raw materials need to be changed to obtain the target compound La013-2 (65.04 g, purity: 99.68%, yield: 83.22%), mass spectrum: 310.08 (M+H)
[0115] Synthesis of compound La013-3
[0116] Referring to the synthesis and purification method of compound La008-4, only the corresponding raw materials need to be changed to obtain the target compound La013-3 (38.59 g, purity: 99.74%, yield: 65.42%), mass spectrum: 292.04 (M+H)
[0117] Synthesis of compound La013-4
[0118] Compound La013-3 (36.00 g, 123.05 mmol), isobutylboronic acid (25.09 g, 246.10 mmol), tris(dibenzylideneacetone)dipalladium (2.25 g, 2.46 mmol), 2-dicyclohexylphosphine-2',6'-dimethoxy-biphenyl (2.09 g, 4.92 mmol), potassium phosphate (52.24 g, 246.10 mmol), and toluene (550 ml) were added to a 1000 ml three-necked round-bottom flask. The atmosphere was replaced with nitrogen three times under vacuum. Under nitrogen protection, the mixture was stirred at 110°C for 2 hours. TLC monitoring (developing solvent: ethyl acetate: petroleum ether = 1:10) indicated complete reaction of the starting material La013-3.
[0119] The temperature was lowered to room temperature, ethyl acetate (200 ml) was added, and the mixture was washed with deionized water (3*300 ml). The liquid was separated, and the organic phase was concentrated and subjected to silica gel column chromatography (200-300 mesh silica gel, eluent: ethyl acetate: petroleum ether = 1:20). After concentration, a white sugar-like solid was obtained, which was compound La013-4 (24.92 g, purity: 99.83%, yield: 75.06%), mass spectrum: 270.12 (M+H).
[0120] Synthesis of compound La013-5
[0121] Referring to the synthesis and purification method of compound La008-11, only the corresponding raw materials need to be changed to obtain the target compound La013-5 (35.07 g, purity: 99.74%, yield: 85.06%), mass spectrum: 402.22 (M+H)
[0122] Synthesis of compound La013
[0123] Referring to the synthesis and purification method of compound La008, only the corresponding raw materials need to be changed to obtain the target compound La013 (25.12 g, purity: 99.75%, yield: 64.33%), mass spectrum: 402.22 (M+H)
[0124] Synthesis of Compound Ir(La013)2(Lb005)
[0125] Synthesis of compound Ir(La013)-1
[0126] Referring to the synthesis and purification methods of compound Ir(La008)-1, only the corresponding raw materials need to be changed to obtain compound Ir(La013)-1 (10.65 g, yield: 76.21%), which was used directly in the next step without purification.
[0127] Synthesis of Compound Ir(La013)2(Lb005)
[0128] Referring to the synthesis and purification methods for compound Ir(La008)2(Lb005), simply by changing the corresponding raw materials, a red solid was obtained, compound Ir(La013)2(Lb005) (6.04 g, purity: 99.78%, yield: 47.77%). 6.04 g of crude Ir(La013)2(Lb005) was purified by sublimation to obtain sublimation-purified Ir(La013)2(Lb005) (3.95 g, purity: 99.75%, yield: 61.59%), mass spectrum: 1205.52 (M+H).
[0129] 1 H NMR (400MHz, CDCl3) δ8.56 (d, J = 2.2Hz, 2H), 8.24-8.19 (m, 2H), 8.18-8.14 (m, 3 H),8.13(s,1H),7.88-7.82(m,4H),7.60(m,2H),7.46(m,2H),7.33(m,2H),7.27 (d,J=9.5Hz,2H),7.20(m,2H),4.79(s,1H),2.71(m,2H),2.62(dt,J=7.0,0.9H z,4H),1.92(m,2H),1.69-1.50(m,16H),1.45-1.26(m,4H),0.91-0.84(m,24H).
[0130] Synthesis of ligand La016
[0131] Synthesis of compound La016-2
[0132] Referring to the synthesis and purification method of compound La008-3, only the corresponding raw materials need to be changed to obtain the target compound La016-2 (40.21 g, purity: 99.84%, yield: 85.26%), mass spectrum: 250.05 (M+H)
[0133] Synthesis of compound La016-3
[0134] Referring to the synthesis and purification method of compound La008-4, only the corresponding raw materials need to be changed to obtain the target compound La016-3 (23.00 g, purity: 99.71%, yield: 63.62%), mass spectrum: 232.14 (M+H)
[0135] Synthesis of compound La016-4
[0136] Referring to the synthesis and purification method of compound La008-11, only the corresponding raw materials need to be changed to obtain the target compound La016-4 (18.62 g, purity: 99.46%, yield: 84.51%), mass spectrum: 364.14 (M+H)
[0137] Synthesis of compound La016
[0138] Referring to the synthesis and purification method of compound La008, it is only necessary to change the corresponding raw materials to obtain the target compound La016 (10.03 g, purity: 99.87%, yield: 56.03%), mass spectrum: 364.14 (M+H).
[0139] 1 H NMR (400MHz, CDCl3) δ9.34 (s, 1H), 8.91 (d, J = 5.6Hz, 1H), 8.43 (d, J = 8.3Hz, 1 H),8.37(d,J=5.6Hz,1H),8.31(s,1H),8.14(s,1H),8.05-8.03(m,1H),7.90 -7.88(m,1H),7.62-7.57(m,1H),7.54-7.47(m,2H),7.42-7.37(m,1H),1.93(s,6H).
[0140] Synthesis of Compound Ir(La016)2(Lb005)
[0141] Synthesis of compound Ir(La016)-1
[0142] Referring to the synthesis and purification methods of compound Ir(La008)-1, only the corresponding raw materials need to be changed to obtain compound Ir(La016)-1 (7.06 g, yield: 78.05%), which was used directly in the next step without purification.
[0143] Synthesis of Compound Ir(La016)2(Lb005)
[0144] Referring to the synthesis and purification methods for compound Ir(La008)2(Lb005), simply by changing the corresponding starting materials, a red solid, compound Ir(La016)2(Lb005) (4.68 g, purity: 99.85%, yield: 48.06%), was obtained. 4.68 g of crude Ir(La016)2(Lb005) was purified by sublimation to obtain sublimation-purified Ir(La016)2(Lb005) (3.02 g, purity: 99.81%, yield: 64.53%), mass spectrum: 1129.40 (M+H).
[0145] 1 H NMR (400MHz, CDCl3) δ8.62 (s, 2H), 8.34 (dd, J = 7.6, 0.8Hz, 2H), 8.24-8.18 (m ,4H),8.16(d,J=2.2Hz,2H),7.88-7.82(m,2H),7.53(t,J=7.6Hz,2H),7.46(t d,J=7.4,1.5Hz,2H),7.33(td,J=7.2,1.1Hz,2H),7.29-7.23(m,4H),4.79(s, 1H),2.71(m,2H),1.67-1.55(m,16H),1.42-1.30(m,4H),0.90-0.86(m,12H).
[0146] Synthesis of Compound Ir(La016)2(Lb007)
[0147] Synthesis of Compound Ir(La016)2(Lb007)
[0148] Referring to the synthesis and purification methods for compound Ir(La008)2(Lb005), only the corresponding starting materials need to be changed to obtain the red solid compound Ir(La016)2(Lb007) (5.36 g, purity: 99.88%, yield: 49.06%). 5.36 g of crude Ir(La016)2(Lb007) was purified by sublimation to obtain sublimation-purified Ir(La016)2(Lb007) (3.48 g, purity: 99.85%, yield: 64.93%), with a mass spectrum of 1157.42 (M+H).
[0149] 1H NMR (400MHz, CDCl3) δ8.44(s,2H),8.41(d,J=8.3Hz,2H),8.17(d,J=6.5Hz,2H),7.9 5(d,J=6.6Hz,2H),7.65-7.59(m,6H),7.45-7.40(m,2H),7.10-7.06(m,2H),6.48-6 .45(m,4H),5.32(s,1H),2.20(s,6H),1.88(s,6H),1.38-1.27(m,4H),1.06-1.01(m ,2H),0.98-0.92(m,2H),0.71(s,6H),0.31(t,J=7.4Hz,6H),0.16(t,J=7.3Hz,6H).
[0150] Synthesis of ligand La018
[0151] Synthesis of compound La018-3
[0152] Compound La018-2 (41.02 g, 499.37 mmol) and tetrahydrofuran (410 ml) were added to a 2000 ml three-necked round-bottom flask. The atmosphere was replaced with nitrogen three times under vacuum. Under nitrogen protection, the system was cooled to -50°C. After the internal temperature dropped to the specified temperature, n-butyllithium solution (313 ml, 1.6 mol / L n-hexane solution) was added dropwise over 1 hour. The mixture was stirred at -50°C for 1 hour. La018-1 (30.00 g, 249.69 mmol) was dissolved in 150 ml and added dropwise to the above low-temperature system over 30 minutes. Stirring was continued for 30 minutes. TLC monitoring (developing solvent: ethyl acetate: petroleum ether = 1:15) showed that the reaction of the raw material La018-1 was complete.
[0153] Deionized water (100 ml) was added dropwise to the system to quench the reaction, and the temperature was raised to room temperature. The organic solvent was removed by concentration under reduced pressure, and ethyl acetate (900 ml) was added. The mixture was washed with deionized water (3*300 ml), and the mixture was allowed to stand for separation. The organic phase was concentrated under reduced pressure at 65 ° C. and then subjected to silica gel column chromatography (200-300 mesh silica gel, eluent: ethyl acetate: petroleum ether = 1:25). After elution, the mixture was concentrated under reduced pressure at 65 ° C. for 1 hour to obtain a light yellow liquid as compound La018-3 (43.14 g, purity: 99.76%, yield: 85.41%), mass spectrum: 203.12 (M+H).
[0154] Synthesis of compound La018-4
[0155] Compound La018-3 (40.00 g, 197.73 mmol) and dichloromethane (800 ml) were added to a 2000 ml three-necked round-bottom flask and stirred at room temperature. Dess-Martin periodinane (88.05 g, 207.61 mmol) was added in batches over 1 hour, and then stirred at room temperature for 2 hours. TLC monitoring (developing solvent: ethyl acetate: petroleum ether = 1:10) showed that the raw material La018-3 was completely reacted.
[0156] The mixture was washed with deionized water (3*400 ml), allowed to stand and separate, and the organic phase was concentrated under reduced pressure at 65°C and then subjected to silica gel column chromatography (200-300 mesh silica gel, eluent: ethyl acetate: petroleum ether = 1:20). After elution, the mixture was concentrated under reduced pressure at 65°C for 1 hour to obtain a light yellow liquid, compound La018-4 (35.66 g, purity: 99.88%, yield: 90.05%), mass spectrum: 201.02 (M+H).
[0157] Synthesis of compound La018-5
[0158] Compound La018-4 (32.00 g, 159.78 mmol) and acetonitrile (350 ml) were added to a 1000 ml three-necked round-bottom flask. The atmosphere was replaced with nitrogen three times under vacuum. Stirring was started at room temperature. Iodine monochloride (51.88 g, 319.55 mmol) was added dropwise over 15 minutes. The mixture was then stirred at room temperature for 4 hours. TLC monitoring (developing solvent: ethyl acetate: petroleum ether = 1:15) showed that the reaction of the raw material La018-4 was complete.
[0159] The reaction was quenched by adding a saturated aqueous sodium bisulfite solution (100 ml), stirred at room temperature for 30 minutes, and the organic phase was concentrated to remove the organic phase; ethyl acetate (600 ml) was added thereto, washed with deionized water (3*250 ml), allowed to stand for separation, and the organic phase was concentrated under reduced pressure at 65°C and then subjected to silica gel column chromatography (200-300 mesh silica gel, eluent: ethyl acetate: petroleum ether = 1:25). After elution, the mixture was concentrated under reduced pressure at 65°C for 1 hour to give a white liquid as compound La018-5 (36.51 g, purity: 99.80%, yield: 70.06%), mass spectrum: 327.02 (M+H).
[0160] Synthesis of compound La018-6
[0161] Referring to the synthesis and purification method of compound La008-7, only the corresponding raw materials need to be changed to obtain compound La018-6 (26.51 g, purity: 99.00%, yield: 85.14%), mass spectrum: 241.06 (M+H)
[0162] Synthesis of compound La018-7
[0163] Referring to the synthesis and purification method of compound La008-8, only the corresponding raw materials need to be changed to obtain compound La018-7 (38.09 g, purity: 99.52%, yield: 88.67%), mass spectrum: 373.12 (M+H)
[0164] Synthesis of compound La018-8
[0165] Referring to the synthesis and purification method of compound La008-10, only the corresponding raw materials need to be changed to obtain compound La018-8 (25.33 g, purity: 98.75%, yield: 80.06%), mass spectrum: 351.22 (M+H)
[0166] Synthesis of compound La018-9
[0167] Referring to the synthesis and purification method of compound La008-11, only the corresponding raw materials need to be changed to obtain compound La018-9 (30.05 g, purity: 99.66%, yield: 84.11%), mass spectrum: 420.20 (M+H)
[0168] Synthesis of compound La018
[0169] Referring to the synthesis and purification method of compound La008, only the corresponding raw materials need to be changed to obtain compound La018 (21.03 g, purity: 99.81%, yield: 56.26%), mass spectrum: 420.20 (M+H)
[0170] Synthesis of Compound Ir(La018)2(Lb005)
[0171] Synthesis of compound Ir(La018)-1
[0172] Referring to the synthesis and purification methods of compound Ir(La008)-1, only the corresponding raw materials need to be changed to obtain compound Ir(La018)-1 (14.65 g, yield: 78.78%), which was used directly in the next step without purification.
[0173] Synthesis of Compound Ir(La018)2(Lb005)
[0174] Referring to the synthesis and purification methods for compound Ir(La008)2(Lb005), simply by changing the corresponding starting materials, a red solid, compound Ir(La018)2(Lb005) (8.95 g, purity: 99.89%, yield: 56.51%), was obtained. 8.95 g of crude Ir(La018)2(Lb005) was purified by sublimation to obtain sublimation-purified Ir(La018)2(Lb005) (6.74 g, purity: 99.83%, yield: 75.31%), with a mass spectrum of 1241.54 (M+H).
[0175] 1 H NMR (400MHz, CDCl3) δ8.53(s,2H),8.34(dd,J=7.6,0.8Hz,2H),8.23-8.15(m,4H),7.82(dd,J=6.8,1.6Hz,2H),7.53(t,J=7.6Hz,2H),7.47(m,2H ),7.37(td,J=7.6,1.3Hz,2H),7.29-7.23(m,4H),4.79(s,1H),2.71(m, 2H),1.67-1.54(m,4H),1.51(s,12H),1.38(s,22H),0.90-0.85(m,12H).
[0176] Synthesis of ligand La029
[0177] Synthesis of compound La029-2
[0178] Referring to the synthesis and purification method of compound La008-3, only the corresponding raw materials need to be changed to obtain the target compound La029-2 (35.12 g, purity: 99.62%, yield: 83.52%), mass spectrum: 257.06 (M+H)
[0179] Synthesis of compound La029-3
[0180] Referring to the synthesis and purification method of compound La008-4, only the corresponding raw materials need to be changed to obtain the target compound La029-3 (26.06 g, purity: 99.75%, yield: 67.16%), mass spectrum: 239.14 (M+H)
[0181] Synthesis of compound La029-5
[0182] Referring to the synthesis and purification method of compound La008-10, only the corresponding raw materials need to be changed to obtain the target compound La029-5 (32.85 g, purity: 98.02%, yield: 76.45%), mass spectrum: 285.12 (M+H)
[0183] Synthesis of compound La029-6
[0184] Referring to the synthesis and purification method of compound La008-11, only the corresponding raw materials need to be changed to obtain the target compound La029-6 (30.25 g, purity: 99.53%, yield: 82.12%), mass spectrum: 361.14 (M+H)
[0185] Synthesis of compound La029-7
[0186] Referring to the synthesis and purification method of compound La008-8, only the corresponding raw materials need to be changed to obtain the target compound La029-7 (43.33 g, purity: 99.62%, yield: 89.56%), mass spectrum: 493.06 (M+H)
[0187] Synthesis of compound La029-8
[0188] Referring to the synthesis and purification method of compound La008-7, only the corresponding raw materials need to be changed to obtain the target compound La029-8 (31.23 g, purity: 99.68%, yield: 84.23%), mass spectrum: 385.12 (M+H)
[0189] Synthesis of compound La029
[0190] Referring to the synthesis and purification method of compound La008, only the corresponding raw materials need to be changed to obtain the target compound La029 (16.02 g, purity: 99.89%, yield: 54.33%), mass spectrum: 385.12 (M+H)
[0191] Synthesis of Compound Ir(La029)2(Lb005)
[0192] Synthesis of compound Ir(La029)-1
[0193] Referring to the synthesis and purification methods of compound Ir(La008)-1, only the corresponding raw materials need to be changed to obtain compound Ir(La029)-1 (13.63 g, yield: 72.11%), which was used directly in the next step without purification.
[0194] Synthesis of Compound Ir(La029)2(Lb005)
[0195] Referring to the synthesis and purification methods for compound Ir(La008)2(Lb005), simply by changing the corresponding starting materials, a red solid, compound Ir(La029)2(Lb005) (9.85 g, purity: 99.88%, yield: 43.56%), was obtained. 9.85 g of crude Ir(La029)2(Lb005) was purified by sublimation to obtain sublimation-purified Ir(La029)2(Lb005) (7.41 g, purity: 99.84%, yield: 75.23%), with a mass spectrum of 1171.22 (M+H).
[0196] 1 H NMR (400MHz, CDCl3) δ8.52-8.47(m,4H),8.36(dd,J=7.4,1.5Hz,2H),8.20(d,J =9.5Hz,2H),7.84(dd,J=7.7,1.5Hz,2H),7.71(dd,J=6.8,1.3Hz,2H),7.52(t,J =6.6Hz,2H),7.46-7.33(m,4H),7.27(d,J=9.5Hz,2H),4.82(s,1H),2.73-2.68( m,2H),2.34(s,6H),1.67-1.54(m,16H),1.42-1.30(m,4H),0.92-0.87(m,12H).
[0197] Synthesis of ligand La048
[0198] Synthesis of compound La048-2
[0199] Referring to the synthesis and purification method of compound La008-11, only the corresponding raw materials need to be changed to obtain the target compound La048-2 (25.45 g, purity: 99.51%, yield: 84.76%), mass spectrum: 346.16 (M+H)
[0200] Synthesis of compound La048
[0201] Referring to the synthesis and purification method of compound La008, only the corresponding raw materials need to be changed to obtain the target compound La048 (14.65 g, purity: 99.89%, yield: 56.12%), mass spectrum: 346.16 (M+H)
[0202] Synthesis of Compound Ir(La048)2(Lb007)
[0203] Synthesis of compound Ir(La048)-1
[0204] Referring to the synthesis and purification methods of compound Ir(La008)-1, only the corresponding raw materials need to be changed to obtain compound Ir(La048)-1 (15.22 g, yield: 75.21%), which was used directly in the next step without purification.
[0205] Synthesis of Compound Ir(La048)2(Lb007)
[0206] Referring to the synthesis and purification methods for compound Ir(La008)2(Lb005), only the corresponding starting materials need to be changed to obtain a red solid compound Ir(La048)2(Lb007) (8.95 g, purity: 99.80%, yield: 45.45%). 8.95 g of crude Ir(La048)2(Lb007) was purified by sublimation to obtain sublimation-purified Ir(La048)2(Lb007) (6.62 g, purity: 99.75%, yield: 73.97%), mass spectrum: 1121.42 (M+H).
[0207] 1 H NMR (400MHz, CDCl3) δ8.63(dd,J=7.3,1.3Hz,2H),8.28(dd,J=7.7,1.4Hz,2H),8.24-8.19(m,2H),8.18-8.10(m,4H),7.88-7.82(m,2H),7.53(dd,J=7 .5,1.1Hz,2H),7.50-7.39(m,6H),7.37-7.29(m,4H),4.82(s,1H),1.68-1. 57(m,16H),1.43-1.33(m,4H),1.05(d,J=15.2Hz,6H),0.88-0.82(m,12H).
[0208] Synthesis of ligand La055
[0209] Synthesis of compound La055-3
[0210] Referring to the synthesis and purification method of compound La008-3, only the corresponding raw materials need to be changed to obtain the target compound La055-3 (38.42 g, purity: 99.42%, yield: 78.08%), mass spectrum: 280.05 (M+H)
[0211] Synthesis of compound La055-4
[0212] Compound La055-3 (35.00 g, 125.10 mmol), (methoxymethyl)triphenylphosphonium chloride (85.77 g, 250.20 mmol), potassium tert-butoxide (28.07 g, 250.20 mmol), and tetrahydrofuran (530 ml) were added to a 2000 ml three-necked round-bottom flask. The flask was purged with nitrogen three times under vacuum and stirred at room temperature for 4 hours. TLC monitoring (developing solvent: ethyl acetate: petroleum ether = 1:10) indicated complete reaction of the starting material La055-3.
[0213] 200 ml of deionized water was slowly added to the system to quench the reaction, and the organic solvent was removed by concentration under reduced pressure. Ethyl acetate (800 ml) was added, and the mixture was washed with deionized water (3*300 ml). The mixture was allowed to stand for separation. The organic phase was concentrated under reduced pressure at 65 ° C. and then subjected to silica gel column chromatography (200-300 mesh silica gel, eluent: ethyl acetate: petroleum ether = 1:20). After elution, the mixture was concentrated under reduced pressure at 65 ° C. for 1 hour to obtain a white solid as compound La055-4 (33.89 g, purity: 99.75%, yield: 88.00%), mass spectrum: 308.06 (M+H).
[0214] Synthesis of compound La055-5
[0215] Referring to the synthesis and purification method of compound La008, only the corresponding raw materials need to be changed to obtain the target compound La055-5 (22.32 g, purity: 99.62%, yield: 83.03%), mass spectrum: 276.05 (M+H)
[0216] Synthesis of compound La055-6
[0217] Referring to the synthesis and purification method of compound La008-11, only the corresponding raw materials need to be changed to obtain the target compound La055-6 (24.89 g, purity: 99.73%, yield: 84.21%), mass spectrum: 408.16 (M+H)
[0218] Synthesis of compound La055
[0219] Referring to the synthesis and purification method of compound La008, only the corresponding raw materials need to be changed to obtain the target compound La055 (11.44 g, purity: 99.81%, yield: 52.01%), mass spectrum: 408.16 (M+H)
[0220] Synthesis of Compound Ir(La055)2(Lb005)
[0221] Synthesis of compound Ir(La055)-1
[0222] Referring to the synthesis and purification methods of compound Ir(La008)-1, only the corresponding raw materials need to be changed to obtain compound Ir(La055)-1 (17.77 g, yield: 74.04%), which was used directly in the next step without purification.
[0223] Synthesis of Compound Ir(La055)2(Lb005)
[0224] Referring to the synthesis and purification methods for compound Ir(La008)2(Lb005), only the corresponding raw materials need to be changed to obtain a red solid compound Ir(La055)2(Lb005) (8.06 g, purity: 99.84%, yield: 46.56%). 8.06 grams of crude Ir(La055)2(Lb005) were sublimed and purified to obtain sublimation-purified Ir(La055)2(Lb005) (5.55 g, purity: 99.78%, yield: 68.86%), mass spectrum: 1217.46 (M+H).
[0225] 1 H NMR (400MHz, CDCl3) δ8.44 (d, J = 9.0 Hz, 2H), 8.24-8.19 (m, 4H), 8.16 (d, J = 2. 3Hz,2H),7.88-7.82(m,2H),7.46-7.33(m,4H),7.25(d,J=9.1Hz,2H),7.06(m 2H),4.72(s,1H),2.73-2.66(m,6H),1.93(dt,J=13.7,6.8Hz,2H),1.67-1.55(m,16H),1.36-1.34(m,4H),0.92-0.84(m,24H).
[0226] Synthesis of ligand La070
[0227] Synthesis of compound La070-3
[0228] Referring to the synthesis and purification method of compound La008-3, only the corresponding raw materials need to be changed to obtain the target compound La070-3 (32.22 g, purity: 99.53%, yield: 80.65%), mass spectrum: 304.03 (M+H)
[0229] Synthesis of compound La070-4
[0230] Compound La070-3 (30.00 g, 98.76 mmol), cesium carbonate (64.35 g, 197.51 mmol), and N,N-dimethylformamide (450 ml) were added to a 1000 ml three-necked round-bottom flask. The atmosphere was replaced with nitrogen three times under vacuum. Under nitrogen protection, the mixture was heated to 100°C and stirred for 2 hours. TLC monitoring (developing solvent: ethyl acetate: petroleum ether = 1:15) indicated complete reaction of the starting material La070-3.
[0231] The organic solvent was removed by concentration under reduced pressure, ethyl acetate (600 ml) was added, and the mixture was washed with deionized water (3*200 ml). The mixture was allowed to stand for separation. The organic phase was concentrated under reduced pressure at 65°C and then subjected to silica gel column chromatography (200-300 mesh silica gel, eluent: ethyl acetate: petroleum ether = 1:30). After elution, the mixture was concentrated under reduced pressure at 65°C for 1 hour to give a white solid as compound La070-4 (21.19 g, purity: 99.85%, yield: 75.60%), mass spectrum: 284.02 (M+H).
[0232] Synthesis of compound La070-5
[0233] Referring to the synthesis and purification method of compound La008-11, only the corresponding raw materials need to be changed to obtain the target compound La070-5 (18.06 g, purity: 99.86%, yield: 83.54%), mass spectrum: 416.12 (M+H)
[0234] Synthesis of compound La070
[0235] Referring to the synthesis and purification method of compound La008, only the corresponding raw materials need to be changed to obtain the target compound La070 (10.02 g, purity: 99.78%, yield: 54.33%), mass spectrum: 416.12 (M+H)
[0236] Synthesis of Compound Ir(La070)2(Lb005)
[0237] Synthesis of Compound Ir(La070)-1
[0238] Referring to the synthesis and purification methods of compound Ir(La008)-1, only the corresponding raw materials need to be changed to obtain compound Ir(La070)-1 (14.33 g, yield: 72.11%), which was used directly in the next step without purification.
[0239] Synthesis of Compound Ir(La070)2(Lb005)
[0240] Referring to the synthesis and purification methods for compound Ir(La008)2(Lb005), only the corresponding starting materials need to be changed to obtain a red solid compound Ir(La070)2(Lb005) (7.62 g, purity: 99.80%, yield: 47.62%). 7.62 g of crude Ir(La070)2(Lb005) was purified by sublimation to obtain sublimation-purified Ir(La070)2(Lb005) (5.35 g, purity: 99.78%, yield: 70.21%), mass spectrum: 1233.40 (M+H).
[0241] 1 H NMR (400MHz, CDCl3) δ8.37(d,J=9.1Hz,2H),8.28-8.14(m,8H),7.88-7.82(m,2H),7.46-7.42(m,2H),7.38-7.30(m,4H),7.28- 7.22(m,4H),4.72(s,1H),2.71-2.69(m,2H),2.60(d,J=0.7Hz,6H),1.68-1.54(m,16H),1.43-1.28(m,4H),0.88-0086(m,12H).
[0242] Synthesis of Compound Ir(La070)2(Lb031)
[0243] Synthesis of Compound Ir(La070)2(Lb031)
[0244] Referring to the synthesis and purification methods for compound Ir(La008)2(Lb005), only the corresponding raw materials need to be changed to obtain the red solid compound Ir(La070)2(Lb031) (8.33 g, purity: 99.82%, yield: 48.52%). 8.33 g of crude Ir(La070)2(Lb031) was purified by sublimation to obtain sublimation-purified Ir(La070)2(Lb031) (6.14 g, purity: 99.78%, yield: 73.71%), mass spectrum: 1257.40 (M+H).
[0245] 1H NMR (400MHz, CDCl3) δ8.37 (d, J = 9.2Hz, 2H), 8.28-8.14 (m, 8H), 7.88-7.82 (m ,2H),7.46(td,J=7.4,1.5Hz,2H),7.38-7.30(m,4H),7.28-7.22(m,4H),4.51 (s,1H),2.60(d,J=0.7Hz,6H),2.50(m,4H),1.88-1.76(m,2H),1.63-1.55(m ,13H),1.55-1.50(m,6H),1.49(m,1H),1.46-1.37(m,4H),1.35-1.21(m,4H).
[0246] Synthesis of ligand La079
[0247] Synthesis of compound La079-2
[0248] Referring to the synthesis and purification method of compound La008-3, only the corresponding raw materials need to be changed to obtain the target compound La079-2 (40.56 g, purity: 99.64%, yield: 85.48%), mass spectrum: 290.20 (M+H)
[0249] Synthesis of compound La079-3
[0250] Referring to the synthesis and purification method of compound La070-4, only the corresponding raw materials need to be changed to obtain the target compound La079-3 (35.41 g, purity: 99.83%, yield: 86.56%), mass spectrum: 270.02 (M+H)
[0251] Synthesis of compound La079-5
[0252] Compound La079-4 (35.00 g, 128.90 mmol) and tetrahydrofuran (350 ml) were added to a 1000 ml three-necked round-bottom flask. The atmosphere was replaced with nitrogen three times under vacuum. Under nitrogen protection, the system was cooled to -78°C. After the internal temperature dropped to the specified temperature, n-butyllithium solution (88.70 ml, 1.6 mol / L n-hexane solution, 141.79 mmol) was added dropwise over 40 minutes. The mixture was stirred at -70°C for 1 hour. Trimethylsilyl chloride (28.00 g, 257.80 mmol) was added dropwise to the above low-temperature system using a constant pressure dropping funnel. The addition was completed over 15 minutes. Stirring was continued for 1 hour. TLC monitoring (developing solvent: ethyl acetate: petroleum ether = 1:20) showed that the reaction of the raw material La079-4 was complete.
[0253] Deionized water (100 ml) was added dropwise to the system to quench the reaction, and the temperature was raised to room temperature. The organic solvent was removed by concentration under reduced pressure, and ethyl acetate (600 ml) was added. The mixture was washed with deionized water (3*200 ml). The mixture was allowed to stand for separation. The organic phase was concentrated under reduced pressure at 65°C and then subjected to silica gel column chromatography (200-300 mesh silica gel, eluent: ethyl acetate: petroleum ether = 1:35). After elution, the mixture was concentrated under reduced pressure at 65°C for 1 hour to give a light yellow liquid as compound La079-5 (23.23 g, purity: 99.87%, yield: 68.06%), mass spectrum: 265.06 (M+H).
[0254] Synthesis of compound La079-6
[0255] Compound La079-5 (23.00 g, 86.85 mmol) and dichloromethane (300 ml) were added to a 500 ml three-necked round-bottom flask and replaced with nitrogen under vacuum three times. Under nitrogen protection, the system was cooled to -20°C. After the internal temperature dropped to the specified temperature, boron tribromide (26.11 g, 104.22 mmol) was added dropwise over 30 minutes. The mixture was stirred at -20°C for 1 hour and monitored by TLC (developing solvent: ethyl acetate: petroleum ether = 1:10). The reaction of the raw material La079-5 was complete.
[0256] Deionized water (100 ml) was then added dropwise to the system to quench the reaction, cooled to room temperature, allowed to stand for separation, washed with deionized water (3 * 150 ml), allowed to stand for separation, and the organic phase was concentrated under reduced pressure at 65 ° C. and then subjected to silica gel column chromatography (200-300 mesh silica gel, eluent ethyl acetate: petroleum ether = 1:20). After elution, the mixture was concentrated under reduced pressure at 65 ° C. for 1 hour to give a light yellow liquid as compound La079-6 (20.70 g, purity: 99.90%, yield: 95.02%), mass spectrum: 251.06 (M+H).
[0257] Synthesis of compound La079-7
[0258] Referring to the synthesis and purification method of compound La008-10, only the corresponding raw materials need to be changed to obtain the target compound La079-7 (18.61 g, purity: 99.78%, yield: 77.06%), mass spectrum: 343.18 (M+H)
[0259] Synthesis of compound La079-8
[0260] Referring to the synthesis and purification method of compound La008-11, only the corresponding raw materials need to be changed to obtain the target compound La079-8 (17.24 g, purity: 99.82%, yield: 82.45%), mass spectrum: 450.12 (M+H)
[0261] Synthesis of compound La079-9
[0262] Referring to the synthesis and purification method of compound La008-8, only the corresponding raw materials need to be changed to obtain the target compound La079-9 (28.05 g, purity: 99.85%, yield: 92.22%), mass spectrum: 582.08 (M+H)
[0263] Synthesis of compound La079-10
[0264] Referring to the synthesis and purification method of compound La008-11, only the corresponding raw materials need to be changed to obtain the target compound La079-10 (31.58 g, purity: 99.81%, yield: 79.69%), mass spectrum: 474.16 (M+H)
[0265] Synthesis of compound La079
[0266] Referring to the synthesis and purification method of compound La008, only the corresponding raw materials need to be changed to obtain the target compound La079 (15.23 g, purity: 99.64%, yield: 55.87%), mass spectrum: 474.16 (M+H)
[0267] Synthesis of Compound Ir(La079)2(Lb005)
[0268] Synthesis of Compound Ir(La079)-1
[0269] Referring to the synthesis and purification methods of compound Ir(La008)-1, only the corresponding raw materials need to be changed to obtain compound Ir(La070)-1 (18.96 g, yield: 74.19%), which was used directly in the next step without purification.
[0270] Synthesis of Compound Ir(La079)2(Lb005)
[0271] Referring to the synthesis and purification methods for compound Ir(La008)2(Lb005), only the corresponding starting materials need to be changed to obtain a red solid compound Ir(La079)2(Lb005) (10.00 g, purity: 99.79%, yield: 46.52%). 10.00 g of crude Ir(La079)2(Lb005) was purified by sublimation to obtain sublimation-purified Ir(La070)2(Lb005) (7.35 g, purity: 99.71%, yield: 73.50%), mass spectrum: 1349.44 (M+H).
[0272] 1H NMR (400MHz, CDCl3) δ8.37 (d, J = 9.2Hz, 2H), 8.26-8.21 (m, 2H), 8.20-8.15 (m ,2H),8.09(s,2H),7.94-7.89(m,2H),7.88-7.83(m,2H),7.54-7.47(m,4H),7 .38-7.30(m,4H),7.25(d,J=9.2Hz,2H),4.72(s,1H),2.71(m,2H),1.68(s,6 H),1.66-1.54(m,10H),1.43-1.30(m,4H),0.92-0.88(m,12H),0.46(s,18H).
[0273] Synthesis of ligand La090
[0274] Synthesis of compound La090-3
[0275] Referring to the synthesis and purification method of compound La008-3, only the corresponding raw materials need to be changed to obtain the target compound La090-3 (33.25 g, purity: 99.56%, yield: 82.11%), mass spectrum: 346.08 (M+H)
[0276] Synthesis of compound La090-4
[0277] Referring to the synthesis and purification method of compound La070-4, only the corresponding raw materials need to be changed to obtain the target compound La090-4 (24.25 g, purity: 99.71%, yield: 74.32%), mass spectrum: 326.06 (M+H)
[0278] Synthesis of compound La090-5
[0279] Referring to the synthesis and purification method of compound La008-11, only the corresponding raw materials need to be changed to obtain the target compound La090-5 (28.79 g, purity: 99.83%, yield: 85.41%), mass spectrum: 458.20 (M+H)
[0280] Synthesis of compound La090
[0281] Referring to the synthesis and purification method of compound La008, only the corresponding raw materials need to be changed to obtain the target compound La090 (16.55 g, purity: 99.78%, yield: 52.11%), mass spectrum: 458.20 (M+H)
[0282] Synthesis of Compound Ir(La090)2(Lb005)
[0283] Synthesis of Compound Ir(La090)-1
[0284] Referring to the synthesis and purification methods of compound Ir(La008)-1, only the corresponding raw materials need to be changed to obtain compound Ir(La090)-1 (18.96 g, yield: 72.43%), which was used directly in the next step without purification.
[0285] Synthesis of Compound Ir(La090)2(Lb005)
[0286] Referring to the synthesis and purification methods for compound Ir(La008)2(Lb005), simply by changing the corresponding starting materials, a red solid, compound Ir(La090)2(Lb005) (8.53 g, purity: 99.78%, yield: 42.45%), was obtained. 8.53 g of crude Ir(La090)2(Lb005) was purified by sublimation to obtain sublimation-purified Ir(La090)2(Lb005) (6.51 g, purity: 99.68%, yield: 76.31%), with a mass spectrum of 1317.42 (M+H).
[0287] 1 H NMR(400MHz, CDCl3)δ8.45(d,J=2.5Hz,2H),8.24-8.20(m,2H),8.20-8.15(m,2H),8.02(d ,J=2.1Hz,2H),7.93(dd,J=9.3,2.2Hz,2H),7.88-7.82(m,2H),7.46(m,2H),7.38-7.33(m ,4H),7.33-7.26(m,2H),7.10(m,2H),4.82(s,1H),2.75-2.66(m,6H),1.90-1.88(m,2H), 1.67-1.60(m,9H),1.60-1.54(m,1H),1.52(s,6H),1.43-1.28(m,4H),0.92-0.84(m,24H).
[0288] Synthesis of ligand La095
[0289] Synthesis of compound La095-2
[0290] Referring to the synthesis and purification method of compound La008-3, only the corresponding raw materials need to be changed to obtain the target compound La095-2 (36.98 g, purity: 99.76%, yield: 86.11%), mass spectrum: 290.01 (M+H)
[0291] Synthesis of compound La095-3
[0292] Referring to the synthesis and purification method of compound La070-4, only the corresponding raw materials need to be changed to obtain the target compound La095-3 (25.08 g, purity: 99.68%, yield: 74.32%), mass spectrum: 270.02 (M+H)
[0293] Synthesis of compound La095-4
[0294] Referring to the synthesis and purification method of compound La008-11, only the corresponding raw materials need to be changed to obtain the target compound La095-4 (18.77 g, purity: 99.73%, yield: 82.51%), mass spectrum: 458.20 (M+H)
[0295] Synthesis of compound La095
[0296] Referring to the synthesis and purification method of compound La008, only the corresponding raw materials need to be changed to obtain the target compound La095 (10.09 g, purity: 99.86%, yield: 54.99%), mass spectrum: 458.20 (M+H)
[0297] Synthesis of Compound Ir(La095)2(Lb005)
[0298] Synthesis of Compound Ir(La095)-1
[0299] Referring to the synthesis and purification methods of compound Ir(La008)-1, only the corresponding raw materials need to be changed to obtain compound Ir(La095)-1 (15.44 g, yield: 68.98%), which was used directly in the next step without purification.
[0300] Synthesis of Compound Ir(La095)2(Lb005)
[0301] Referring to the synthesis and purification methods for compound Ir(La008)2(Lb005), only the corresponding raw materials need to be changed to obtain a red solid compound Ir(La095)2(Lb005) (7.22 g, purity: 99.86%, yield: 45.55%). 7.22 grams of crude Ir(La095)2(Lb005) were sublimed and purified to obtain sublimation-purified Ir(La095)2(Lb005) (5.67 g, purity: 99.68%, yield: 78.53%), mass spectrum: 1317.40 (M+H).
[0302] 1H NMR (400MHz, CDCl3) δ8.53 (d, J = 2.4Hz, 2H), 8.26-8.21 (m, 2H), 8.18 (dd, J = 7. 3,1.5Hz,2H),7.96-7.89(m,4H),7.82(dd,J=6.8,1.6Hz,2H),7.54-7.50(m,2 H),7.50-7.44(m,4H),7.40-7.32(m,4H),4.78(s,1H),2.71-2.68(m,2H),1.6 7-1.55(m,4H),1.51(s,6H),1.47(s,6H),1.38(s,22H),0.88-0.86(qm,12H).
[0303] Synthesis of Compound Ir(La095)2(Lb043)
[0304] Synthesis of Compound Ir(La095)2(Lb043)
[0305] Referring to the synthesis and purification methods for compound Ir(La008)2(Lb005), only the corresponding raw materials need to be changed to obtain a red solid compound Ir(La095)2(Lb043) (6.21 g, purity: 99.80%, yield: 41.12%). 6.21 g of crude Ir(La095)2(Lb043) was purified by sublimation to obtain sublimation-purified Ir(La095)2(Lb043) (4.22 g, purity: 99.71%, yield: 67.96%), mass spectrum: 1287.37 (M+H).
[0306] 1 H NMR (400MHz, CDCl3) δ8.53(d,J=2.4Hz,2H),8.24(m,2H),8.18(dd,J=7.3,1.5Hz,2H),7.96-7.89(m,4H),7.82(dd,J=6.8,1.5Hz,2H), 7.55-7.44(m,6H),7.40-7.32(m,4H),4.64(s,1H),2.79-2.76(m,1H),1.51(s,6H),1.47(s,6H),1.38(s,18H),1.07(d,J=6.1Hz,6H).
[0307] Synthesis of ligand La103
[0308] Synthesis of compound La103-2
[0309] Referring to the synthesis and purification method of compound La008-3, only the corresponding raw materials need to be changed to obtain the target compound La103-2 (38.01 g, purity: 99.73%, yield: 82.77%), mass spectrum: 274.04 (M+H)
[0310] Synthesis of compound La103-3
[0311] Referring to the synthesis and purification method of compound La070-4, only the corresponding raw materials need to be changed to obtain the target compound La103-3 (31.02 g, purity: 99.81%, yield: 75.45%), mass spectrum: 254.04 (M+H)
[0312] Synthesis of compound La103-4
[0313] Referring to the synthesis and purification method of compound La008-11, only the corresponding raw materials need to be changed to obtain the target compound La103-4 (38.21 g, purity: 99.75%, yield: 79.91%), mass spectrum: 386.15 (M+H)
[0314] Synthesis of compound La103
[0315] Referring to the synthesis and purification method of compound La008, only the corresponding raw materials need to be changed to obtain the target compound La103 (16.77 g, purity: 99.81%, yield: 54.23%), mass spectrum: 386.15 (M+H)
[0316] Synthesis of Compound Ir(La103)2(Lb005)
[0317] Synthesis of Compound Ir(La103)-1
[0318] Referring to the synthesis and purification methods of compound Ir(La008)-1, only the corresponding raw materials need to be changed to obtain compound Ir(La103)-1 (18.96 g, yield: 76.68%), which was used directly in the next step without purification.
[0319] Synthesis of Compound Ir(La103)2(Lb005)
[0320] Referring to the synthesis and purification methods for compound Ir(La008)2(Lb005), only the corresponding starting materials need to be changed to obtain a red solid compound Ir(La103)2(Lb005) (9.84 g, purity: 99.79%, yield: 42.41%). 9.84 g of crude Ir(La103)2(Lb005) was purified by sublimation to obtain sublimation-purified Ir(La103)2(Lb005) (7.35 g, purity: 99.68%, yield: 74.70%), mass spectrum: 1173.42 (M+H).
[0321] 1 H NMR (400MHz, CDCl3) δ8.70 (s, 2H), 8.24-8.19 (m, 2H), 8.16 (d, J = 2.3Hz, 2H), 8.01-7.95 (m, 2H), 7.88-7.81 (m, 4H), 7.66-7.61 (m, 2H), 7.50-7 .39(m,6H),7.33(m,2H),7.23(d,J=10.8Hz,2H),4.79(s,1H),2.71-2. 67(m,2H),1.68-1.54(m,16H),1.43-1.28(m,4H),0.88-0.85(m,12H).
[0322] Synthesis of ligand La112
[0323] Synthesis of compound La112-2
[0324] Referring to the synthesis and purification method of compound La008-3, only the corresponding raw materials need to be changed to obtain the target compound La112-2 (32.12 g, purity: 99.88%, yield: 80.14%), mass spectrum: 288.04 (M+H)
[0325] Synthesis of compound La112-3
[0326] Referring to the synthesis and purification method of compound La070-4, only the corresponding raw materials need to be changed to obtain the target compound La112-3 (22.01 g, purity: 99.75%, yield: 76.56%), mass spectrum: 268.05 (M+H)
[0327] Synthesis of compound La112-4
[0328] Referring to the synthesis and purification method of compound La008-11, only the corresponding raw materials need to be changed to obtain the target compound La112-4 (28.11 g, purity: 99.68%, yield: 80.03%), mass spectrum: 390.10 (M+H)
[0329] Synthesis of compound La112-4
[0330] Referring to the synthesis and purification method of compound La008-8, only the corresponding raw materials need to be changed to obtain the target compound La112-4 (40.56 g, purity: 99.79%, yield: 92.11%), mass spectrum: 522.08 (M+H)
[0331] Synthesis of compound La112-6
[0332] Referring to the synthesis and purification method of compound La008-7, only the corresponding raw materials need to be changed to obtain the target compound La112-6 (29.89 g, purity: 99.84%, yield: 86.46%), mass spectrum: 414.16 (M+H)
[0333] Synthesis of compound La112
[0334] Referring to the synthesis and purification method of compound La008, only the corresponding raw materials need to be changed to obtain the target compound La112 (14.53 g, purity: 99.74%, yield: 52.63%), mass spectrum: 414.16 (M+H)
[0335] Synthesis of Compound Ir(La112)2(Lb005)
[0336] Synthesis of Compound Ir(La112)-1
[0337] Referring to the synthesis and purification methods of compound Ir(La008)-1, only the corresponding raw materials need to be changed to obtain compound Ir(La112)-1 (12.65 g, yield: 72.11%), which was used directly in the next step without purification.
[0338] Synthesis of Compound Ir(La112)2(Lb005)
[0339] Referring to the synthesis and purification methods for compound Ir(La008)2(Lb005), only the corresponding starting materials need to be changed to obtain a red solid compound Ir(La112)2(Lb005) (6.53 g, purity: 99.74%, yield: 42.12%). 6.53 g of crude Ir(La112)2(Lb005) was purified by sublimation to obtain sublimation-purified Ir(La112)2(Lb005) (4.45 g, purity: 99.70%, yield: 68.15%), mass spectrum: 1229.46 (M+H).
[0340] 1 H NMR (400MHz, CDCl3) δ8.64(s,2H),8.36-8.34(m,2H),8.04(d,J=7.8Hz,2H),7.87-7.81(m,4H),7.46-7.33(m,4H),7.23(d,J=10.8Hz,2H),7.19-7 .13(m,2H),6.90-6.86(m,2H),4.79(s,1H),2.71-6.68(m,2H),2.34(d,J =8.7Hz,12H),1.67-1.54(m,16H),1.43-1.28(m,4H),0.90-0.87(m,12H).
[0341] Synthesis of Compound Ir(La112)2(Lb007)
[0342] Synthesis of Compound Ir(La112)2(Lb007)
[0343] Referring to the synthesis and purification methods for compound Ir(La008)2(Lb005), only the corresponding starting materials need to be changed to obtain a red solid compound Ir(La112)2(Lb007) (7.05 g, purity: 99.78%, yield: 43.25%). 7.05 g of crude Ir(La112)2(Lb007) was purified by sublimation to obtain sublimation-purified Ir(La112)2(Lb007) (5.35 g, purity: 99.70%, yield: 75.89%), mass spectrum: 1257.20 (M+H).
[0344] 1H NMR(400MHz, CDCl3) δ8.63(s,2H),8.36(dd,J=7.4,1.5Hz,2H),8.04(d,J=7.8 Hz,2H),7.87-7.81(m,4H),7.46-7.33(m,4H),7.23(d,J=10.8Hz,2H),7.16(m, 2H),6.90-6.86(m,2H),5.83(s,1H),2.34(d,J=8.7Hz,12H),1.69-1.57(m,4H) ,1.56(s,12H),1.44-1.32(m,4H),1.05(d,J=15.2Hz,6H),0.88-0.82(m,12H).
[0345] Synthesis of ligand La132
[0346] Synthesis of compound La132-3
[0347] Referring to the synthesis and purification method of compound La008-3, only the corresponding raw materials need to be changed to obtain the target compound La132-3 (40.52 g, purity: 99.80%, yield: 82.66%), mass spectrum: 298.02 (M+H)
[0348] Synthesis of compound La132-4
[0349] Compound La132-3 (35.00 g, 117.55 mmol) and tetrahydrofuran (350 ml) were added to a 1000 ml three-necked round-bottom flask. The system was replaced with nitrogen three times under vacuum. Under nitrogen protection, the system was cooled to 0°C. After the internal temperature dropped to the specified temperature, methylmagnesium chloride solution (86.21 ml, 3 mol / L tetrahydrofuran solution, 258.62 mmol) was added dropwise. The addition was completed over 1 hour. The mixture was maintained at 0°C and stirred for 1 hour. TLC monitoring (developing solvent: ethyl acetate: petroleum ether = 1:15) showed that the raw material La132-3 was completely reacted.
[0350] Aqueous hydrochloric acid solution (133 ml, 4 mol / L, 530.00 mmol) was added dropwise to the system to quench the reaction. The organic solvent was removed by concentration under reduced pressure, ethyl acetate (700 ml) was added, and the mixture was washed with deionized water (3*300 ml). The mixture was allowed to stand for separation. The organic phase was concentrated under reduced pressure at 65°C and then subjected to silica gel column chromatography (200-300 mesh silica gel, eluent: ethyl acetate: petroleum ether = 1:30). After elution, the mixture was concentrated under reduced pressure at 65°C for 1 hour to give a light yellow liquid as compound La132-4 (28.74 g, purity: 99.79%, yield: 82.11%), mass spectrum: 298.08 (M+H).
[0351] Synthesis of compound La132-5
[0352] Compound La132-4 (25.00 g, 83.95 mmol) and dichloromethane (250 ml) were added to a 500 ml three-necked round-bottom flask and replaced with nitrogen in vacuum three times. Under nitrogen protection, the system was cooled to 0°C. After the internal temperature dropped to the specified temperature, methanesulfonic acid (16.14 g, 167.91 mmol) was added dropwise. The mixture was stirred at 0°C for 1 hour and monitored by TLC (developing solvent: ethyl acetate: petroleum ether = 1:25). The reaction of the raw material La132-3 was complete.
[0353] 100 ml of deionized water was added to the system to quench the reaction, and the mixture was allowed to stand for separation. The organic solvent was removed by concentration under reduced pressure, and silica gel column chromatography (200-300 mesh silica gel, eluent: ethyl acetate: petroleum ether = 1:25) was performed. After elution, the mixture was concentrated under reduced pressure at 65°C for 1 hour to obtain a light yellow liquid, compound La132-5 (20.07 g, purity: 99.83%, yield: 85.47%), mass spectrum: 280.08 (M+H)
[0354] Synthesis of compound La132-6
[0355] Referring to the synthesis and purification method of compound La008-11, only the corresponding raw materials need to be changed to obtain the target compound La132-6 (27.60 g, purity: 99.80%, yield: 82.56%), mass spectrum: 468.26 (M+H)
[0356] Synthesis of compound La132
[0357] Referring to the synthesis and purification method of compound La008, only the corresponding raw materials need to be changed to obtain the target compound La132 (12.44 g, purity: 99.73%, yield: 51.01%), mass spectrum: 468.26 (M+H)
[0358] Synthesis of Compound Ir(La132)2(Lb005)
[0359] Synthesis of compound Ir(La132)-1
[0360] Referring to the synthesis and purification methods of compound Ir(La008)-1, only the corresponding raw materials need to be changed to obtain compound Ir(La132)-1 (10.67 g, yield: 74.22%), which was used directly in the next step without purification.
[0361] Synthesis of Compound Ir(La132)2(Lb005)
[0362] Referring to the synthesis and purification methods for compound Ir(La008)2(Lb005), only the corresponding starting materials need to be changed to obtain a red solid compound Ir(La132)2(Lb005) (5.89 g, purity: 99.87%, yield: 41.01%). 5.89 g of crude Ir(La132)2(Lb005) was purified by sublimation to obtain sublimation-purified Ir(La132)2(Lb005) (4.22 g, purity: 99.77%, yield: 71.65%), mass spectrum: 1337.24 (M+H).
[0363] 1 H NMR (400MHz, CDCl3) δ8.26(s,2H),8.21-8.12(m,4H),8.00-7.95(m,2H),7.82(dd,J=6.8,1.6Hz,2H),7.58(dd,J=7.3,1.5Hz,2H),7.51-7. 44(m,4H),7.40-7.33(m,6H),4.79(s,1H),2.71(m,2H),1.75(s,12H) ,1.68-1.54(m,4H),1.51(s,12H),1.38(s,22H),0.91-0.88(m,12H).
[0364] Synthesis of ligand La162
[0365] Synthesis of compound La162-2
[0366] Referring to the synthesis and purification method of compound La008-11, only the corresponding raw materials need to be changed to obtain the target compound La162-2 (22.90 g, purity: 99.85%, yield: 81.60%), mass spectrum: 392.10 (M+H)
[0367] Synthesis of compound La162-3
[0368] Referring to the synthesis and purification method of compound La008-8, only the corresponding raw materials need to be changed to obtain the target compound La162-3 (35.23, purity: 99.75%, yield: 88.97%), mass spectrum: 524.06 (M+H)
[0369] Synthesis of compound La162-4
[0370] Referring to the synthesis and purification method of compound La008-7, only the corresponding raw materials need to be changed to obtain the target compound La162-4 (20.67, purity: 99.68%, yield: 82.69%), mass spectrum: 416.14 (M+H)
[0371] Synthesis of compound La162
[0372] Referring to the synthesis and purification method of compound La008, only the corresponding raw materials need to be changed to obtain the target compound La162 (11.34, purity: 99.78%, yield: 50.05%), mass spectrum: 416.14 (M+H)
[0373] Synthesis of Compound Ir(La162)2(Lb005)
[0374] Synthesis of Compound Ir(La162)-1
[0375] Referring to the synthesis and purification methods of compound Ir(La008)-1, only the corresponding raw materials need to be changed to obtain compound Ir(La162)-1 (16.88 g, yield: 71.09%), which was used directly in the next step without purification.
[0376] Synthesis of Compound Ir(La162)2(Lb005)
[0377] Referring to the synthesis and purification methods for compound Ir(La008)2(Lb005), only the corresponding starting materials need to be changed to obtain a red solid compound Ir(La162)2(Lb005) (9.93 g, purity: 99.87%, yield: 43.78%). 9.93 g of crude Ir(La162)2(Lb005) was purified by sublimation to obtain sublimation-purified Ir(La162)2(Lb005) (7.75 g, purity: 99.80%, yield: 78.04%), mass spectrum: 1233.40 (M+H).
[0378] 1 H NMR (400MHz, CDCl3) δ8.41-8.34(m,4H),8.22-8.15(m,2H),7.91-7.81(m,4H),7.56-7.47(m,6H),7.46-7.33(m,6H), 4.72(s,1H),2.71-2.68(m,2H),2.34(s,6H),1.68-1.54(m,4H),1.52(s,12H),1.43-1.28(m,4H),0.88-0.86(m,12H).
[0379] Synthesis of ligand La175
[0380] Synthesis of compound La175-2
[0381] Referring to the synthesis and purification method of compound La008-11, only the corresponding raw materials need to be changed to obtain the target compound La175-2 (18.56 g, purity: 99.81%, yield: 82.05%), mass spectrum: 386.16 (M+H)
[0382] Synthesis of compound La175
[0383] Referring to the synthesis and purification method of compound La008, only the corresponding raw materials need to be changed to obtain the target compound La175 (8.90, purity: 99.77%, yield: 50.00%), mass spectrum: 386.16 (M+H)
[0384] Synthesis of Compound Ir(La175)2(Lb005)
[0385] Synthesis of Compound Ir(La175)-1
[0386] Referring to the synthesis and purification methods of compound Ir(La008)-1, only the corresponding raw materials need to be changed to obtain compound I Ir(La175)-1 (12.44 g, yield: 72.57%), which was used directly in the next step without purification.
[0387] Synthesis of Compound Ir(La175)2(Lb005)
[0388] Referring to the synthesis and purification methods for compound Ir(La008)2(Lb005), only the corresponding starting materials need to be changed to obtain a red solid compound Ir(La175)2(Lb005) (7.66 g, purity: 99.83%, yield: 40.00%). 7.66 g of crude Ir(La175)2(Lb005) was purified by sublimation to obtain sublimation-purified Ir(La175)2(Lb005) (4.77 g, purity: 99.80%, yield: 62.28%), mass spectrum: 1173.42 (M+H).
[0389] 1H NMR (400MHz, CDCl3) δ8.24-8.19(m,2H),8.16(d,J=2.3Hz,2H),7.97(dd,J=9.5,1.4 Hz,2H),7.89-7.82(m,4H),7.56-7.54(m,4H),7.50-7.30(m,10H),4.79(s,1 H),2.71(m,2H),1.68-1.54(m,16H),1.43-1.28(m,4H),0.89-0.86(m,12H).
[0390] Synthesis of ligand La181
[0391] Synthesis of compound La181-3
[0392] Referring to the synthesis and purification method of compound La008-3, only the corresponding raw materials need to be changed to obtain the target compound La181-3 (28.88 g, purity: 99.74%, yield: 80.01%), mass spectrum: 282.02 (M+H)
[0393] Synthesis of compound La181-4
[0394] Referring to the synthesis and purification method of compound La008-4, only the corresponding raw materials need to be changed to obtain the target compound La181-4 (12.35 g, purity: 99.79%, yield: 68.06%), mass spectrum: 264.03 (M+H)
[0395] Synthesis of compound La181-5
[0396] Referring to the synthesis and purification method of compound La008-11, only the corresponding raw materials need to be changed to obtain the target compound La181-5 (19.25 g, purity: 99.83%, yield: 85.41%), mass spectrum: 452.22 (M+H)
[0397] Synthesis of compound La181
[0398] Referring to the synthesis and purification method of compound La008, only the corresponding raw materials need to be changed to obtain the target compound La181 (9.33 g, purity: 99.80%, yield: 53.32%), mass spectrum: 452.22 (M+H)
[0399] Synthesis of Compound Ir(La181)2(Lb005)
[0400] Synthesis of Compound Ir(La181)-1
[0401] Referring to the synthesis and purification methods of compound Ir(La008)-1, only the corresponding raw materials need to be changed to obtain compound I Ir(La181)-1 (15.35 g, yield: 73.33%), which was used directly in the next step without purification.
[0402] Synthesis of Compound Ir(La181)2(Lb005)
[0403] Referring to the synthesis and purification methods for compound Ir(La008)2(Lb005), only the corresponding starting materials need to be changed to obtain a red solid compound Ir(La181)2(Lb005) (8.55 g, purity: 99.80%, yield: 42.22%). 8.55 g of crude Ir(La181)2(Lb005) was purified by sublimation to obtain sublimation-purified Ir(La181)2(Lb005) (6.41 g, purity: 99.80%, yield: 74.97%), mass spectrum: 1305.52 (M+H).
[0404] 1 H NMR(400MHz, CDCl3)δ8.59(d,J=8.9Hz,2H),8.54(s,2H),8.45-8.40(m,2H),8.23-8 .15(m,4H),7.96(d,J=9.2Hz,2H),7.92-7.87(m,2H),7.82(dd,J=6.9,1.5Hz,2H),7. 56-7.44(m,6H),7.37(td,J=7.6,1.3Hz,2H),7.27(d,J=9.5Hz,2H),4.80(s,1H),2. 71-2.67(m,2H),1.67-1.54(m,4H),1.51(s,12H),1.38(s,22H),0.90-0.88(m,12H).
[0405] Synthesis of ligand La2O2
[0406] Synthesis of compound La202-1
[0407] Referring to the synthesis and purification method of compound La008-11, only the corresponding raw materials need to be changed to obtain the target compound La202-1 (35.06 g, purity: 99.74%, yield: 81.11%), mass spectrum: 376.12 (M+H)
[0408] Synthesis of compound La2O2-2
[0409] Referring to the synthesis and purification method of compound La008-8, only the corresponding raw materials need to be changed to obtain the target compound La202-2 (46.56 g, purity: 99.76%, yield: 88.62%), mass spectrum: 508.04 (M+H)
[0410] Synthesis of compound La2O2-3
[0411] Referring to the synthesis and purification method of compound La008-7, only the corresponding raw materials need to be changed to obtain the target compound La202-3 (37.06 g, purity: 99.83%, yield: 84.21%), mass spectrum: 400.06 (M+H)
[0412] Synthesis of compound La2O2-4
[0413] Referring to the synthesis and purification method of compound La008, only the corresponding raw materials need to be changed to obtain the target compound La202-4 (18.52 g, purity: 99.78%, yield: 53.63%), mass spectrum: 400.06 (M+H)
[0414] Synthesis of compound La2O2
[0415] La202-4 (15.00 g, 37.55 mmol), potassium tert-butoxide (8.43 g, 75.10 mmol), and deuterated dimethyl sulfoxide (150 ml) were added to a 500 ml three-necked round-bottom flask. The atmosphere was replaced with nitrogen three times under vacuum, and the mixture was heated to 90°C and reacted overnight for 24 h. The reaction of La202-4 was completed by NMR monitoring.
[0416] The reaction solution was added dropwise to deionized water (500 ml), ethyl acetate (500 ml) was added, and the mixture was stirred at room temperature for 30 minutes. The mixture was separated, and the organic phase was washed with deionized water (3*150 ml). The mixture was separated, and the organic phase was concentrated and subjected to silica gel column chromatography (200-300 mesh silica gel, eluent ethyl acetate: petroleum ether = 1:10). After concentration, a white solid was obtained, which was compound La202 (14.37 g, purity: 99.82%, deuteration rate: 99.46%, yield: 95.55%), mass spectrum: 401.16 (M+H).
[0417] Synthesis of Compound Ir(La2O2)2(Lb005)
[0418] Synthesis of compound Ir(La2O2)-1
[0419] Referring to the synthesis and purification methods of compound Ir(La008)-1, only the corresponding raw materials need to be changed to obtain compound Ir(La202)-1 (16.56 g, yield: 7565%), which was used directly in the next step without purification.
[0420] Synthesis of Compound Ir(La2O2)2(Lb005)
[0421] Referring to the synthesis and purification methods of compound Ir(La008)2(Lb005), only the corresponding raw materials need to be changed to obtain a red solid compound Ir(La202)2(Lb005) (9.63 g, purity: 99.82%, yield: 43.13%). 963 grams of crude Ir(La202)2(Lb005) were sublimed and purified to obtain sublimation-purified Ir(La202)2(Lb005) (7.56 g, purity: 99.80%, yield: 78.52%), mass spectrum: 1203.44 (M+H).
[0422] 1 H NMR(400MHz, CDCl3)δ8.63(s,2H),8.36(dd,J=7.4,1.5Hz,2H),8.01-7.95(m,2H),7.89(s,2H),7.84(m,2H),7.66-7.61(m,2H),7.44-7 .39(m,6H),7.37-7.34(m,2H),4.79(s,1H),2.71-2.67(m,2H),2.34(s,6H),1.67-1.54(m,16H),1.42-1.30(m,4H),0.89-0.87(m,12H).
[0423] Synthesis of ligand La210
[0424] Synthesis of compound La210-2
[0425] Referring to the synthesis and purification method of compound La008-3, only the corresponding raw materials need to be changed and the reaction time is extended to 15 hours to obtain the target compound La210-2 (20.03 g, purity: 99.74%, yield: 65.03%), mass spectrum: 215.03 (M+H)
[0426] Synthesis of compound La210-3
[0427] Referring to the synthesis and purification method of compound La008-11, only the corresponding raw materials need to be changed to obtain the target compound La210-3 (18.65 g, purity: 99.65%, yield: 85.96%), mass spectrum: 347.15 (M+H)
[0428] Synthesis of compound La2101
[0429] Referring to the synthesis and purification method of compound La008, only the corresponding raw materials need to be changed to obtain the target compound La210 (10.85 g, purity: 99.76%, yield: 60.00%), mass spectrum: 347.15 (M+H)
[0430] Synthesis of Compound Ir(La210)2(Lb005)
[0431] Synthesis of Compound Ir(La210)-1
[0432] Referring to the synthesis and purification methods of compound Ir(La008)-1, only the corresponding raw materials need to be changed to obtain compound Ir(La210)-1 (12.63 g, yield: 76.36%), which was used directly in the next step without purification.
[0433] Synthesis of Compound Ir(La210)2(Lb005)
[0434] Referring to the synthesis and purification methods for compound Ir(La008)2(Lb005), only the corresponding starting materials need to be changed to obtain a red solid compound Ir(La210)2(Lb005) (8.33 g, purity: 99.82%, yield: 43.13%). 8.33 g of crude Ir(La210)2(Lb005) was purified by sublimation to obtain sublimation-purified Ir(La210)2(Lb005) (6.00 g, purity: 99.80%, yield: 72.03%), mass spectrum: 1095.41 (M+H).
[0435] 1H NMR (400MHz, CDCl3) δ8.33-8.27(m,2H),8.25-8.17(m,6H),8.02(dd,J=7.5 ,1.4Hz,2H),7.88-7.82(m,2H),7.69-7.62(m,2H),7.52-7.43(m,4H),7.33 (td,J=7.2,1.1Hz,2H),7.25(d,J=9.5Hz,2H),4.79(s,1H),2.74-2.71(m,2 H),1.68(s,12H),1.66-1.54(m,4H),1.43-1.28(m,4H),0.88-0.86(m,12H).
[0436] Synthesis of ligand La214
[0437] Synthesis of compound La214-2
[0438] Referring to the synthesis and purification method of compound La008-3, only the corresponding raw materials need to be changed to obtain the target compound La214-2 (25.96 g, purity: 99.33%, yield: 83.52%), mass spectrum: 286.15 (M+H)
[0439] Synthesis of compound La214-3
[0440] Referring to the synthesis and purification method of compound La008-11, only the corresponding raw materials need to be changed to obtain the target compound La214-3 (22.11 g, purity: 99.45%, yield: 78.98%), mass spectrum: 355.12 (M+H)
[0441] Synthesis of compound La214-4
[0442] Referring to the synthesis and purification method of compound La008-8, only the corresponding raw materials need to be changed to obtain the target compound La214-4 (19.88 g, purity: 99.60%, yield: 75.96%), mass spectrum: 487.07 (M+H)
[0443] Synthesis of compound La214
[0444] Referring to the synthesis and purification method of compound La008, only the corresponding raw materials need to be changed to obtain the target compound La214 (18.75 g, purity: 99.78%, yield: 62.75%), mass spectrum: 379.15 (M+H)
[0445] Synthesis of Compound Ir(La214)2(Lb005)
[0446] Synthesis of Compound Ir(La214)-1
[0447] Referring to the synthesis and purification methods of compound Ir(La008)-1, only the corresponding raw materials need to be changed to obtain compound Ir(La214)-1 (14.63 g, yield: 77.06%), which was used directly in the next step without purification.
[0448] Synthesis of Compound Ir(La214)2(Lb005)
[0449] Referring to the synthesis and purification methods for compound Ir(La008)2(Lb005), only the corresponding starting materials need to be changed to obtain a red solid compound Ir(La214)2(Lb005) (10.52 g, purity: 99.80%, yield: 46.75%). 10.52 g of crude Ir(La214)2(Lb005) was purified by sublimation to obtain sublimation-purified Ir(La214)2(Lb005) (7.86 g, purity: 99.75%, yield: 74.71%), mass spectrum: 1159.41 (M+H).
[0450] 1 H NMR(400MHz, CDCl3)δ8.78(dd,J=4.1,2.1Hz,2H),8.53(s,2H),8.46(dd,J=7.4, 2.1Hz,2H),8.34(dd,J=7.6,0.8Hz,2H),8.20(d,J=9.3Hz,2H),7.53(t,J=7.6Hz,2H),7.29-7.20(m,6H), 4.79(s,1H),2.92(s,6H),2.74-2.68(m,2H),1.68-1.54(m,16H),1.43-1.28(m,4H),0.88-0.85(m,12H).
[0451] Application example: Fabrication of organic electroluminescent devices
[0452] 50mm*50mm*1.0mm with ITO The glass substrate of the anode electrode was ultrasonically cleaned in ethanol for 10 minutes, dried at 150 degrees, and then treated with N2 plasma for 30 minutes. The washed glass substrate was mounted on the substrate holder of the vacuum evaporation device. First, the compound HTM1 and P-dopant (ratio 97%:3%) were co-evaporated on the surface of the anode electrode line in a manner that covered the electrode to form a film with a thickness of A thin film is then deposited, followed by a layer of HTM1 to form a film with a thickness of A thin film of about 1000 nm is formed, and then a layer of HTM2 is evaporated on the HTM1 film to form a film with a thickness of about 100 nm. Then, the main material H1 and the main material H2 and the doping compound (ratio: 48.5%: 48.5%: 3%, compared with compound X and the compound of the present application) are evaporated on the HTM2 film layer in a co-evaporation mode, and the film thickness is ETL: LiQ( The ratio is 50%:50%), and then Yb is evaporated on the electron transport layer material. Finally, a layer of metal iridium Ag is evaporated As an electrode.
[0453] Evaluation: The above devices were subjected to device performance tests. In each embodiment and comparative example, a constant current power supply (Keithley 2400) was used, and a fixed current density flow (20 mA / cm 2 ) tested IVL data and measured the luminescence spectrum using a spectroradiometer (CS2000). The voltage value and the time it takes for the luminance to reach 95% of the initial luminance (LT95) were also measured. The results are as follows: The device current efficiency and lifetime were calculated based on the values of comparative compound 3 as 100%.
[0454] From the comparison of the data in the above table, it can be seen that the iridium complex prepared using the compound of the present application using a specific phenylisoquinoline-locked naphthyl as a ligand has a strong rigid structure, which suppresses the vibration of the molecule. The compound has a narrow half-peak width. In the organic electroluminescent device as a dopant, in the same device, compared with the comparative compounds 1-3, it shows more superior performance in driving voltage, luminous efficiency, and device life.
[0455] Through a unique combination of substituents, this application unexpectedly provides improved device luminous efficiency and lifetime compared to the prior art, with a narrower half-width (FWHM) and saturated red luminescence. These results demonstrate that the compounds of this application exhibit advantages such as a low sublimation temperature, high optical and electrochemical stability, high color saturation, high luminous efficiency, and long device lifetime, making them suitable for use in organic electroluminescent devices. In particular, as red-emitting dopants, they have potential applications in the OLED industry, particularly for displays, lighting, and automotive taillights.
Claims
1. A metal iridium complex having the general formula of Ir(La)(Lb)(Lc), and having a structural formula as shown in formula (1), in is the ligand La; wherein Z is independently selected from CR A R B ; in, X 1 -X 9 N or CR independently 0 , the adjacent substituent R 0 can optionally be linked to form a ring; Where X 1 -X 5 There are at least two adjacent CRs 0 They are connected to each other to form an aromatic ring with 6 to 30 carbon atoms or a heteroaromatic ring with 3 to 30 carbon atoms; Where R 0 , R, R A , R B independently selected from hydrogen, deuterium, halogen, substituted or unsubstituted alkyl with 1-10 main chain carbon atoms, substituted or unsubstituted cycloalkyl with 3-20 ring carbon atoms, substituted or unsubstituted heteroalkyl with 1-10 main chain carbon atoms, substituted or unsubstituted heterocycloalkyl with 3-20 ring carbon atoms, substituted or unsubstituted C3-C30 alkylsilyl, substituted or unsubstituted C3-C30 alkylgermanyl, substituted or unsubstituted C1-C10 Alkoxy, substituted or unsubstituted C7-C30 aralkyl, substituted or unsubstituted C6-C30 aryloxy, substituted or unsubstituted C2-C20 alkenyl, substituted or unsubstituted C2-C20 alkynyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C3-C30 heteroaryl, substituted or unsubstituted C3-C30 arylsilyl, substituted or unsubstituted C0-C20 alkylamino, cyano, isocyano, phosphino; Among them, the R 0 , R, R A , R B The substitution is substituted by deuterium, F, Cl, Br, C1-C4 alkyl, C1-C4 alkoxy, C3-C6 cycloalkyl, C1-C4 alkyl substituted amine, C6-C10 aryl, C1-C4 alkyl substituted C6-C10 aryl, cyano, isocyano, phosphino; wherein the heteroatom in the heteroalkyl group, heterocycloalkyl group, heteroaromatic ring or heteroaryl group is at least one of S, O, Se, N, Si, Ge, B and P; Among them, Lb and Lc are both monoanionic bidentate ligands, or La, Lb and Lc are arbitrarily connected to each other in pairs. Form a multidentate ligand, or three connected by a group; Wherein, the structural formula of Lb and / or Lc is as follows: shown.
2. The metal iridium complex according to claim 1, in, The ligand La has one of the following structural formulas (2) to (19): Wherein Y is selected from O, S, Se, CR A R B 、SiR A R B ,GeR A R B NR A R B , BR A R B , PR A R B , Y 1 -Y 8 N or CR independently 0 , the adjacent substituent R 0 can optionally be linked to form a ring; Among them, X 1 -X 9 , R 0 , R, R A , R B , Z are consistent with the above definitions.
3. The metal iridium complex according to claim 1, in, R is hydrogen, a substituted or unsubstituted alkyl group having 1 to 10 carbon atoms, a substituted or unsubstituted cycloalkyl group having 3 to 20 ring carbon atoms, a substituted or unsubstituted C3-C30 alkylsilyl group, or a substituted or unsubstituted C3-C30 alkylgermanyl group.
4. The metal iridium complex according to claim 1, in, The ligand La has the following structural formula (22): Among them, X 1 -X 5 , R 0 , R, Z are consistent with the above definitions; R 1 -R 4 independently selected from hydrogen, deuterium, halogen, substituted or unsubstituted alkyl having 1-10 main chain carbon atoms, substituted or unsubstituted cycloalkyl having 3-20 ring carbon atoms, substituted or unsubstituted heteroalkyl having 1-10 main chain carbon atoms, substituted or unsubstituted heterocycloalkyl having 3-20 ring carbon atoms, substituted or unsubstituted C3-C30 alkylsilyl, substituted or unsubstituted C1-C10 alkoxy, substituted or unsubstituted C7-C30 aralkyl, substituted or unsubstituted C6-C30 aryloxy, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C3-C30 heteroaryl, substituted or unsubstituted C3-C30 arylsilyl, substituted or unsubstituted C0-C20 alkylamino, cyano, isocyano, phosphino, and the adjacent substituent R 1 -R 4 can be optionally linked to form a ring, wherein R 1 -R 4 The substitution is substituted by deuterium, F, Cl, Br, C1-C4 alkyl, C1-C4 alkoxy, C3-C6 cycloalkyl, amine substituted by C1-C4 alkyl, C6-C10 aryl, C6-C10 aryl substituted by C1-C4 alkyl, cyano, isocyano.
5. The metal iridium complex according to claim 4, in, The ligand La is selected from one of the following structural formulas (23)-(24): Among them, X 1 -X 3 N or CR independently 0 , and X 1 -X 3 There are two adjacent CR 0 Connected to each other to form an aromatic ring of 6 to 30 carbon atoms or a heteroaromatic ring of 3 to 30 carbon atoms; Among them, R 0 , R, Z are consistent with the above definitions; R 1 -R 6 independently selected from hydrogen, deuterium, halogen, substituted or unsubstituted alkyl with 1 to 8 main chain carbon atoms, substituted or unsubstituted cycloalkyl with 3 to 10 ring carbon atoms, substituted or unsubstituted a heteroalkyl group having 1 to 8 main chain carbon atoms, a substituted or unsubstituted heterocycloalkyl group having 3 to 10 ring carbon atoms, a substituted or unsubstituted C3-C20 alkylsilyl group, a substituted or unsubstituted C1-C8 alkoxy group, a substituted or unsubstituted C7-C20 aralkyl group, a substituted or unsubstituted C6-C20 aryloxy group, a substituted or unsubstituted C6-C20 aryl group, a substituted or unsubstituted C3-C20 heteroaryl group, a substituted or unsubstituted C3-C30 arylsilyl group, a substituted or unsubstituted C0-C10 alkylamino group, a cyano group, an isocyano group, and the adjacent substituent R 1 -R 4 , R 5 -R 6 can be optionally linked to form a ring, wherein R 1 -R 6 The substitution is substituted by deuterium, F, Cl, Br, C1-C4 alkyl, C1-C4 alkoxy, C3-C6 cycloalkyl, amine substituted by C1-C4 alkyl, C6-C10 aryl, C6-C10 aryl substituted by C1-C4 alkyl, cyano, isocyano.
6. The metal iridium complex according to claim 1, wherein La is independently selected from one of the following structural formulas, or the hydrogen atoms in one of the following structural formulas are partially or completely deuterated, or the hydrogen atoms in one of the following structural formulas are partially or completely fluorinated:
7. The metal iridium complex according to any one of claims 1 to 6, in, Lc and La have the same structure, forming (La) 2 Ir(Lb) structure.
8. The metal iridium complex according to claim 7, in, Lb is the structure shown in formula (21): The dotted line indicates the position connected to the metal iridium Ir; Among them, R a -R g independently selected from hydrogen, deuterium, halogen, substituted or unsubstituted alkyl with 1 to 10 main chain carbon atoms, substituted or unsubstituted cycloalkyl with 3 to 20 ring carbon atoms, substituted or unsubstituted heteroalkyl with 1 to 10 main chain carbon atoms substituted or unsubstituted heterocycloalkyl having 3 to 20 ring carbon atoms or R a , R b , R c They are connected in pairs to form a fatty ring structure, R e , R f , R g are connected in pairs to form a fatty ring structure; wherein the R a -R g The substitution is substituted by deuterium, F, Cl, Br, C1-C4 alkyl, C1-C4 alkoxy, C3-C6 cycloalkyl, C1-C4 alkyl substituted by amino, cyano, isocyano, phosphino.
9. The metal iridium complex according to claim 8, wherein R a , R b , R c R e , R f , R g same.
10. The metal iridium complex according to claim 9, wherein Lb is independently selected from one of the following structural formulae, or the hydrogen atoms in one of the following structural formulae are partially or completely deuterated, or the hydrogen atoms in one of the following structural formulae are partially or completely fluorinated:
11. An electroluminescent device, include: A cathode, an anode and an organic layer arranged between the cathode and the anode, wherein the organic layer comprises the metal iridium complex according to any one of claims 1 to 10. 12 . The electroluminescent device according to claim 11 , wherein the organic layer comprises a light-emitting layer, and the metal iridium complex according to any one of claims 1 to 10 is used as a light-emitting doping material of the light-emitting layer.
Citation Information
Patent Citations
Organometallic compound, organic light-emitting diode having same, and organic light-emitting device
CN114478643A
Polymer luminescent material, organoelectroluminescent element and display device
JP2007254540A
Organic Electroluminescent Materials and Devices
US20170012223A1
